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When encountering external pathogen threats, host cells recognize the conserved 
pathogen-associated molecular patterns (PAMPs) on the pathogens through their 
pattern-recognition receptors such as Toll-like receptors (TLRs), and subsequently 
activate inflammatory responses. Previous studies have shown that different TLRs can 
crosstalk and boost the expression of some inflammatory cytokines to synergistic 
levels. Furthermore, several potential synergistic factors including JunB have been 
found. However, the role of JunB and how it is regulated in macrophages remain 
poorly characterized.  
In this study, results show that both junb mRNA and JunB protein were induced 
under single (polyI:C or R848) and combinatorial (polyI:C and R848) PAMP 
stimulations in macrophages. Characterization of the junb promoter as well as junb 
downstream 3'UTR regions revealed several immune-related transcription factor (TF) 
binding sites such as NF-κB, AP-1 and C/EBPbeta as well as evolutionarily conserved 
regions. Both junb promoter and junb downstream enhancer region are important in 
regulating junb transcription. The junb downstream 3'UTR region is likely to 
cooperate with the promoter in macrophages. Through mutagenesis analysis, we 
found that the four NF-κB sites within junb downstream 3'UTR are important for junb 
transcription. Furthermore, the promoter and enhancer co-pulldown assay followed by 
mass spectrometry facilitated our identification of potentially important TFs which 
may regulate junb transcription under different PAMP stimulations. Several potential 
chromatin binding TFs such as AATF, SSRP1 and TARDBP were identified; their 
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Chapter 1: Introduction 
1.1 The innate immune system and macrophages 
    Throughout life, multicellular organisms encounter external stimuli such 
as microbial pathogens. Then a protective response like inflammation occurs 
to help the host body remove the pathogen and start repairing 
infection-damaged tissues (Medzhitov, 2008). Evolutionarily, the hosts have 
developed defensive mechanisms. Plants and invertebrates depend entirely on 
innate immune system to protect from pathogens. In vertebrates, two immune 
systems cooperate to recognize and fight against infectious microbes--the 
adaptive system and the innate system. The adaptive immune system, which is 
composed of the antigen receptors harboring T and B lymphocytes, helps the 
hosts fight against pathogens by creating specific immunological memory 
cells and generating antibodies. These antigen receptors are not encoded in the 
germ line, so adaptive immune responses are considered highly specific. The 
innate immune system is genetically programmed and it is the important first 
protective line of defense against pathogens. Innate immune system is 
essential for the acute inflammation induced by the detrimental stimuli (Akira 
et al., 2006; Beutler et al., 2006). Innate immune system is also important for 
the activation of adaptive immunity by coordinating with T-lymphocytes and 
B-lymphocytes (Netea et al., 2004; Iwasaki and Medzhitov, 2010). Innate 
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immune cells including dendritic cells (DCs), macrophages and neutrophils 
possess pattern recognition receptors (PRRs) to detect the invariant features 
called pathogen-associated molecular patterns (PAMPs) which are uniquely 
displayed on the invading microbes. 
An intact innate immune response is crucial in keeping the balance of 
physiological conditions of the hosts. Studies have shown that genetic defects 
in PRRs leading to the impaired recognition of invading pathogens increase 
the susceptibility to infection (Netea and van der Meer, 2011). For example, 
paediatric patients with deficiencies in Toll-like receptor 3 (TLR3) or the 
protein UNC93B1 which is involved in TLR3 signaling pathway, suffer from 
recurrent herpes simplex virus encephalitis (Casrouge et al., 2006; Zhang et al., 
2007).Furthermore, the inappropriate immune responses such as 
over-activation also damage the hosts. For example, when PRRs fail to 
distinguish self from microbial components, chronic inflammation may occur, 
and autoimmune diseases can occur. In normal conditions, self nucleic acids 
from damaged cells will be degraded by enzymes in the serum to avoid 
interacting with TLRs like TLR7 and TLR9. When these nucleic acids form 
immune complexes with cellular proteins such as autoantibodies, TLR7 and 
TLR9 pathways can be activated, which trigger autoimmune diseases like 
systemic lupus erythematosus (SLE) (Takeuchi and Akira, 2010). 
    Macrophages have long been considered as important immune cells. 
They are present in all tissues and are differentiated from circulating 
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peripheral-blood mononuclear cells (PBMCs)(Gordon and Taylor, 2005). They 
are phagocytic cells which are involved in clearing erythrocytes and removing 
cellular debris (Mosser and Edwards, 2008). The phagocytosis of detrimental 
components leads to physiological changes in macrophages, including the 
expression of pro-inflammatory cytokines and the alteration expression of 
surface proteins (Mosser and Edwards, 2008). These physiological changes 
can provide macrophages with enhanced antimicrobial activity. These 
functions make macrophages one of the primary sensors and defenders in the 
hosts against stimuli, thus making the investigation in macrophages relating to 
innate immune responses very important. 
 
1.2 Pathogen recognition 
1.2.1 Pathogen-associated molecular patterns (PAMPs) 
    In innate immunity, the host uses its PRRs to distinguish the PAMPs, 
which are uniquely conserved structures present on the microorganisms. 
PAMPs are shared by groups of microbes and are essential for the survival of 
microorganisms, thus it is difficult for pathogens to alter PAMPs in order to 
avoid detection by PRRs (Medzhitov and Janeway, 2000). PAMPs are 
produced only by microbial pathogens but not by the hosts, allowing the 
innate immune system to distinguish pathogens and self-generating molecules. 
They span a wide range from protein, lipoprotein, lipids to nucleic acids 
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derived from various microbes. For example, lipopolysaccharide (LPS) is 
common amongst Gram-negative bacteria while lipoteichoic acid (LTA) is 
shared by Gram-positive bacteria. Another common PAMP is the nucleic acids 
derived from viruses and bacteria and endogenous nucleic acids in pathogenic 
conditions, including single-stranded (ss) RNA and double-stranded (ds) RNA. 
PAMPs also provide the "molecular signatures" of certain pathogen classes, 
enabling the germline-encoded PRRs to detect what type the invading 
pathogen is and how to choose the most efficient defense mechanism to 
counter the infection. 
 
1.2.2 Pathogen recognition receptors (PRRs) 
    So far, four classes of PRRs have been identified according to their 
structures and localization in the host immune-responsive cells. These are: the 
transmembrane Toll-like receptors (TLRs), C-type lectin receptors (CLRs); the 
cytoplasmic NOD-like receptors (NLRs), and the Retinoic acid-inducible gene 
(RIG)-1-like receptors (RLRs) (Takeuchi and Akira, 2010) (Figure 1). The 
main sentinel cells of innate immunity such as DCs and phagocytic cells 
simultaneously express certain specific but overlapping PRRs, which enable 
the tissue-specific responses to microbial infections. When these PRRs (except 
some NLRs) encounter PAMPs stimulations, some genes regulating 
inflammatory responses will be up-regulated, leading to the expression of 
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pro-inflammatory cytokines, type I interferons (IFNs) and other antimicrobial 
proteins, which help to host fight against infection. However, aberrant 
activation of PRRs can lead to septic shock, immunodeficiency or 
autoimmune diseases such as SLE (Takeuchi and Akira, 2010). 
 
Figure 1. Schematic representation of the structure and main signaling 
pathways of the PRR families, including TLRs, CLRs, NLRs, RLRs. Figure 
adapted from (Netea and van der Meer, 2011), with copyright permission. 
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1.3 Toll-like receptors and the signaling pathways 
Among all the PRRs, the TLR family members are the most well-studied. 
Each TLR member is composed of an N-terminal domain with leucine-rich 
repeats (LRRs), a transmembrane region and a cytoplasmic Toll/IL-1R 
homology (TIR) domain. LRRs are involved in ligand binding directly or 
binding through accessory molecules, and TIR domain interacts with adaptor 
proteins (Takeda et al., 2003). To date, ten and twelve TLRs have been 
identified in human and mice, respectively. According to their cellular 
localization, TLRs can be sorted into two subgroups: (i) TLR1, TLR2, TLR4, 
TLR5, TLR6 and TLR11, expressed on the cell surface and sense mainly the 
microbial surface components such as lipid, proteins and lipoproteins, and (ii) 
TLR3, TLR7, TLR8 and TLR9, which reside in the membrane of cytoplasmic 
vesicles such as endosomes, lysosomes and endolysosomes and recognize the 
intracellular microbial nucleic acids (Trinchieri and Sher, 2007) (Figure 2). 
The proper cellular localization of TLRs is important for sensing the 
extracellular or actively engulfed pathogens rather than host intracellular self 
molecules, thus preventing self-activation. 
After sensing PAMPs, TLRs trigger downstream immune responses 
mainly through two pathways, depending on the adaptor proteins used. There 
are five TIR-containing adaptor proteins including myeloid differentiation 
primary-response gene 88 (MyD88), TIR-domain-containing adapter-inducing 
interferon-β (TRIF), TIR-domain-containing adaptor protein (TIRAP/Mal), 
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TRIF-related adaptor molecule (TRAM) and Sterile-alpha and Armadillo 
motif-containing protein (SARM) (Akira et al., 2006). The TLR signaling can 
be roughly divided into two pathways, depending on the adaptor proteins used. 
One is MyD88-dependent pathway, and the other is TRIF-dependent pathway 
(Takeuchi and Akira, 2010). All the TLRs, with the exception of TLR3, use 
MyD88 to trigger downstream signaling. After a series of signaling cascades, 
the activation of MyD88-dependent pathway leads to the translocation of 
nuclear factor-κB (NF-κB) into the nucleus and activation of the expression of 
inflammatory cytokines. MyD88 pathway also leads to the activation of MAP 
kinase cascade, which is responsible for the transcription factor complex, AP-1, 
targeting cytokine genes(Takeuchi and Akira, 2010). Further complexity is 
reported for the association of the adaptor molecule, TIRAP with MyD88, 
which is necessary for the activation of TLR2 and TLR4 (Takeda, Kaisho et al., 
2003). On the other hand, TLR3 and TLR4 use TRIF-dependent signaling 
pathway under PAMP simulations. However, TLR4 needs to recruit another 
adaptor protein, TRAM, to activate TRIF. Upon stimulations and a series of 
signaling cascade, the TRIF-signaling pathway leads to the translocation of 
interferon regulatory factor 3 (IRF3) and IRF7 dimers into the nucleus and the 
subsequent induction of type I IFNs and the expression of IFN-inducible genes 
(Takeuchi and Akira, 2010) (Figure 1). 
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Figure 2. Schematic representation of the structure and main signaling 
pathways of the TLR families. Figure adapted from(Kawai and Akira, 2011), 
with copyright permission. 
 
    These TLRs can each recognize different PAMPs and host 
self-components (Table 1). To be more specific, TLR2 senses the lipoprotein 
on bacteria, viruses, parasites. It forms a heterodimer with either TLR1 or 
TLR6 when binding ligands. TLR1-TLR2 complex recognizes triacyl 
lipoproteins while TLR6-TLR2 complex recognizes diacyl lipoproteins. Upon 
stimulations, the cellular responses (production of pro-inflammatory cytokines 
and type I IFNs) differ depending on various cell types (Barbalat et al., 2009). 
TLR4 senses lipopolysaccharide (LPS) by complexing with myeloid 
differentiation factor 2 (MD2) on the cell surface. A TLR4 homodimer 
containing two complexes of TLR4-MD2-LPS is formed upon ligand binding 
- 9 - 
 
(Park et al., 2009). Another set of TLRs including TLR3, TLR7, TLR8 and 
TLR9 recognize nucleic acids from viruses and bacteria. TLR3 senses viral 
double-stranded (ds) RNA and also polyinosinic polycytidylic acid (poly I:C) 
in the endolysosome. The activation of TLR3 leads to the production of 
cytokines (Kato et al., 2006). Mouse TLR7 and human TLR7/8 recognize 
single-stranded (ss) RNAs from RNA viruses and small purine analog 
compounds such as imidazoquinolines. TLR9 senses unmethylated DNA with 
CpG motifs of bacteria and viruses.  
Table 1. PRRs and their ligands. 
 
Table was adapted from (Takeuchi and Akira, 2010), with copyright 
permission. 
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1.4 PRR crosstalks 
    As described in section 1.2, PRRs recognize specific PAMPs, however, in 
reality, a host may encounter various PAMPs at the same time, whether it is a 
single pathogen or polymicrobial infection, and that the appropriate 
interactions between these PRR pathways are crucial for optimizing the host 
responses. For example, crosstalk between TLRs and CLRs is important for 
anti-fungal innate response (Netea et al., 2008). Upon mycobacterial infection, 
TLRs and NOD2 cooperate to activate the host defense (Netea, Brown et al., 
2008). During infection, one of the CLR, dectin-1, plays a very important role. 
For example, it induces the production of pro-inflammatory cytokines together 
with TLR2 through MAP kinase and NF-κB pathways (Brown et al., 2003; 
Gantner et al., 2003). It also boosts TLR4 responses through Syk-dependent 
pathway (Dennehy et al., 2008). Furthermore, within one PRR family, 
crosstalks also exist. For example, the TLR2 pathway can inhibit the 
production of IL-12 produced by the TLR4 pathway (Agrawal et al., 2003). 
All these studies indicate that cooperations between different PRRs, and 
thence, the respective pathways they mediate, are crucial for regulating the 
complex innate immune responses upon infections. 
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1.5 TLR pathways crosstalks- the synergy effect induced by combinatorial 
PAMPs 
    Many studies have focused attention on revealing the function of single 
TLR upon single PAMP stimulation in immune responses. However in real life, 
to meet the demands of multiple PAMP stimulations during an infection, the 
hosts have developed crosstalk mechanisms amongst PRRs to finely regulate 
and balance immune functions in a timely and optimal level, both to eliminate 
the invading pathogens and to achieve homeostasis in the host immune system. 
Indeed, cooperations between certain TLRs do exist. Some studies have shown 
that challenging the immune cells with certain combinatorial TLR agonists can 
synergistically boost the expression of inflammatory cytokines (Napolitani et 
al., 2005; Roelofs et al., 2005) (Bagchi et al., 2007). For example, stimulating 
murine macrophages with dsRNA (a ligand for TLR3) and CpG DNA (a 
ligand for TLR9) was found to boost the synergistic expression of interleukin 
(IL)-12, tumor necrosis factor α (TNFα) and IL-6 (Whitmore et al., 2004). In 
DCs, combinatorial stimulations with R848 (an analogue single-stranded RNA 
imiquimod ligand for TLR7) and either poly(I:C) (a double-stranded RNA 
recognized by TLR3) or LPS (a ligand for TLR4) will synergize the 
expression level of IL-12 p70 and IFNα/β (Gautier et al., 2005). IL-12 p70 is 
the biologically active form composed of IL-12 p35 and IL-12 p40. The 
molecular mechanisms of the cytokine synergy effect of IL-12 p70 could 
partly be due to the preferential induction of IL-12 p35 by TRIF-dependent 
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pathway and IL-12 p40 by MyD88-dependent pathway. Studies have shown 
that the production of IL-12 p70 in DCs was synergistically induced when 
simultaneously stimulated with TRIF-associated ligand and MyD88-associated 
ligand (Figure 3) (Napolitani, Rinaldi et al., 2005; Roelofs, Joosten et al., 
2005) (Bekeredjian-Ding et al., 2006), suggesting that the two signaling 
pathways might cooperate downstream of adaptors, MyD88 and TRIF.  
    Besides the positive regulation of genes by the stimulations of 
combinatorial TLR ligands, negative regulation (antagonism) also exists. For 
example, the production of cytokine (Re and Strominger, 2004) was 
down-regulated in a synergistic manner. The expression of IL-12 p35 in DCs 
induced by a combinatorial stimulation by TLR3 and TLR4 was blocked by 
the IL-10 produced by TLR2 stimulation (Re and Strominger, 2004). Taken 
together, the regulations of cytokine gene expression by combinatorial TLR 
ligands, either positive or negative, seem to affect the level of cytokines that 
are mainly involved in immune responses against pathogen invasion. 
     
 
Figure 3. Combinations of TLR ligand synergistically induced the production 
of IL-12 p70. Figure adapted from (Trinchieri and Sher, 2007), with copyright 
permission. 
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    Although the complexity of cytokine synergy has been repeatedly 
reported (Napolitani, Rinaldi et al., 2005; Theiner et al., 2008; Zhu et al., 2008) 
(Bohnenkamp et al., 2007; De Nardo et al., 2009; Krummen et al., 2010), 
knowledge is lacking on how macrophages might respond to multiple PAMP 
stimulations, and whether combinatorial PAMPs stimulate cytokine synergy in 
macrophages, after all, macrophages are the first to encounter pathogens and 
are highly innate immune responsive. A recent study has shown that among all 
the TLRs in mouse macrophages, the combinatorial activation of both TLR3 
and TLR7 by poly(I:C) and R848, respectively, yielded the strongest synergy 
effect (Tan et al., 2013). Thus, in this thesis, we have chosen this stimulation 
model for investigating the molecular mechanism(s) related to 
pro-inflammatory cytokine synergy in macrophages.  
    Through a proteomics method: isobaric tag for relative and absolute 
quantification (iTRAQ) analysis of chromatin binding proteins derived from 
different PAMP stimulations, JunB was found to be a critical transcription 
factor candidate which regulates cytokine synergy. JunB belongs to the AP-1 
transcription factor family, and it is shown to regulate immune responses. For 
example, JunB binds to IL-6 and IL12 promoter in regulating the cytokine 
expression under PAMP stimulations (Liu et al., 2015). The detail introduction 
of JunB and its function is given in Section 1.6. Knockdown of junb in mouse 
macrophages impaired the synergistic expression of proinflammatory 
cytokines (Liu, Zhu et al., 2015), suggesting a possible role of junb in 
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regulating the synergy effect. 
1.6 Activator Protein-1 (AP-1) and JunB  
    Activator protein-1 (AP-1) including JunB, regulate many biological 
processes such as cell proliferation, death, survival and differentiation as well 
as immunity. AP-1 is one of the earliest identified transcription factors (Angel 
and Karin, 1991). AP-1 activity, in collaboration with JunB, can be induced by 
various stimuli, suggesting their involvement in regulating stimulations. 
1.6.1 AP-1 and JunB in biological processes 
    AP-1 is not a single protein, instead it is a range of dimers containing 
basic region-leucine zipper (bZIP) proteins that comprises of (i) Jun protein 
family, including JunB, c-Jun and JunD, (ii) Fos family, including c-Fos, Fra-1, 
Fra-2 and FosB, (iii) Maf family, including c-Maf, MafB, MafA, MafG/F/K 
and Nrl) and (iv) ATF family, including ATF2, LRF1/ATF3, B-ATF, JDP1, 
JDP2). The bZIP proteins recognize the 12-O-tetradecanoylphorbol-13-acetate 
(TPA) response elements (5'-TGAG/CTCA-3') or the cAMP response 
elements (CRE, 5'-TGACGTCA-3') (Chinenov and Kerppola, 2001). Jun and 
Fos are the two AP-1 family members that have been better studied. c-Jun has 
been considered as the most potent transcriptional activator and JunB the 
antagonist which can attenuate c-Jun (Chiu et al.; Schütte et al.). AP-1 
functions by either homodimerizing or heterodimerizing with each other. Jun 
can form stable dimers themselves, while Fos proteins do not form dimers but 
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heterodimers with Jun proteins (Halazonetis et al., 1988; Kouzarides and Ziff, 
1988). AP-1 has dual functions, either activating or repressing of transcription, 
depending on the combination of the dimers, the cellular environment, cell 
types, and target genes (Shaulian and Karin, 2002). 
    AP-1 functions in cell proliferation and transformation. For examples, 
mouse embryonic fibroblasts (MEFs) from c-jun
-/-
 embryos have severe 
proliferation defect (Johnson et al., 1993; Schreiber et al., 1999). Foetal 
hepatoblasts from c-jun
-/-
 foetuses also showed reduced proliferation (Eferl et 
al., 1999). On the other hand, JunB is considered a negative regulator of 
proliferation. junb
-/-
 MEFs proliferated normally and MEFs derived from junb 
transgenic mice that overexpressed JunB showed reduced proliferative ability 
(Bakiri et al., 2000). Recently, new evidence showed that JunB may function 
as a positive proliferative regulator in the absence of c-Jun (Passegue et al., 
2002), suggesting that the different functions of JunB and c-Jun may be 
cell-specific. 
    Jun and Fos are also involved in transformation. AP-1 can be activated by 
various tumour promoters as well as activated oncoproteins (Angel and Karin, 
1991). Certain AP-1 proteins, including all Jun proteins can co-operate with 
activated oncogenes such as Ha-Ras in the transformation of rat embryo 
fibroblasts (REFs) (Vandel et al., 1996). Again, c-Jun is most potent in 
transformation ability, and JunB attenuates the ability of c-Jun since 
cotransfection with c-Jun and JunB lowered the transformational ability of 
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c-Jun in primary mouse embryonic fibroblast (MEFs) (Passegué and Wagner, 
2000). 
    AP-1 proteins also participate in regulating cell death and survival, for 
example, in the regulation of apoptosis. Apoptosis suppresses oncogenic 
transformation, controls organogenesis and immune responses. It has been 
found that the induction of c-Fos and c-Jun led to cell death (Buttyan et al., 
1988; Smeyne et al., 1993; Marti et al., 1994). More solid evidences showed 
that an increase of survival of the growth-factor-deprived lymphoid cells was 
observed by using antisense oligonucleotides against c-fos and c-jun (Colotta 
et al., 1992). Inhibition of c-Jun activity was observed to protect neuronal cells 
from apoptosis (Ham et al.; Whitfield et al.; Estus et al., 1994). However, 
c-Jun was also found to have anti-apoptotic activity, since the hepatocytes 
from c-Jun
-/-
 embryos showed massive apoptosis (Hilberg et al., 1993; Eferl, 
Sibilia et al., 1999), and that junb transgene can prevent liver degradation in 
c-Jun
-/-
 embryos (Passegue, Jochum et al., 2002). 
    AP-1 proteins also function in bone formation. The bone homeostasis, 
which is the cooperation and balance between bone resorption by osteoclasts 
and bone formation by osteoblasts, is crucial for maintaining integrated bone 
functions. It was recognized that there is crosstalk between bone cells and 
immune cells, which is not too surprising because osteoblasts and osteoclasts 
reside in proximity with immune cells in bone marrow cavity, and they share 
overlapping regulatory signaling molecules, transcription factors and other 
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molecules. Bone diseases involving immune system have been identified, such 
as periodontal disease and rheumatoid arthritis (RA) (Rodan and Martin, 
2000). AP-1 is of particular importance in the bone and immune systems. Mice 
with inactivated Fra-1 resulted in embryonic lethality due to defects in 
placenta, suggesting that Fra-1 is dispensable in bone formation (Schreiber 
and Hampe, 2000). Mice lacking junb also showed osteoblast and osteoclast 
defects (Kenner et al., 2004). Mice deficient in Fos show severe osteoporosis 
(Grigoriadis et al., 1994; Iotsova et al., 1997). Taken together, Fos and Jun 
proteins are key regulators in bone formation.  
 
1.6.2 AP-1 and JunB in immunity 
   Inflammation occurs when a host encounters pathogen invasion and the 
subsequent recruitment of immune cells to the site of infection-inflammation 
and injury. The immune cell recruitment is regulated by cytokines activated by 
transcription factors such as members of the AP-1, NF-κB and NFAT families. 
    The AP-1 family can influence inflammation through four main 
mechanisms: (i) AP-1 can cooperate with NFAT family to activate the cytokine 
production. Many cytokine genes are regulated by a transcription factor 
complex containing AP-1 and NFAT. This complex was found to 
predominantly contain JunB and Fra-1 proteins (Boise et al., 1993), and other 
AP-1 complexes such as Jun/Fos have been shown to regulate IL-2 expression 
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in cooperation with NFAT (McGuire and Iacobelli, 1997). (ii) Jun/AP-1 
proteins regulate the differentiation of naive T-cell into T-Helper 1 (Th1) or 
Th2 cells, influencing the inflammatory processes. In the process of Th2 cell 
differentiation, JunB accumulates and regulates the expression of IL-4 
positively. JunB was also shown to regulate IL-10 expression in Th2 cells 
(Wang et al., 2005). (iii) AP-1 can interact and trans-repress with 
glucocorticoid receptor (GR). GR is known to repress the pro-inflammatory 
transcription factors, AP-1 and NF-κB, and it can prevent the DNA-bound 
AP-1 complex from interacting with its transcriptional coactivators (Wang, 
Sato et al., 2005). (iv) AP-1 can also modulate the innate immune responses. 
For example, Fos seems to down-regulate the production of TNF-α and IL-12, 
which inhibit the inflammatory cytokine production (Mitsuhashi et al., 2004). 
AP-1 also involves in diseases. The activation of AP-1 leads to the 
up-regulation of the expression of human T cell leukemia virus type 1 
(HTLV-1) viral gene (Grant et al., 2006). AP-1 activation also mediates the 
up-regulation expression of visna virus gene in differentiating monocytes 
(Gabuzda et al., 1989), visna virus belongs to lentivirus subfamily and it 
causes chronic inflammatory disease in lungs, joints and nervous system in 
sheep (Narayan and Cork, 1985). These studies point to the potential 
regulatory role of AP-1 in virus infection. Besides, JunB was discovered to 
function in controlling other immune responses as well. It can cooperate with 
NF-κB in inducing pro-inflammatory cytokines such as TNFα, IL-6 and IL-12 
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in mice bone-marrow-derived dendritic cells (BMDCs) under LPS stimulation 
(Gomard et al., 2010). AP-1 and NF-κB cooperate to regulate the transcription 
of various genes including some cytokines (Fujioka et al., 2004; Krappmann 
et al., 2004; Khalaf et al., 2010). It was also found in mouse macrophage cell 
lines, J774 and RAW264.7, that JunB was activated under LPS stimulation 
(Frazier-Jessen et al.; Fujihara et al., 1993). However, these studies mainly 
focused on LPS stimulation and single PAMP stimulation. Whether JunB plays 
a role in macrophages regulating immune responses under combinatorial 
PAMP stimulation and how JunB functions in immune regulation under 
multiple infection conditions remain largely unknown.  
 
1.6.3 The junb gene 
    junb is considered an early response gene. Previous study in BMDCs 
showed that junb mRNA increased rapidly from the basal level and returned to 
basal level within 4 h (Gomard, Michaud et al., 2010). Unlike the transient 
accumulation of junb mRNA, the JunB protein levels increase and remain 
stable for more than 24 h. The mechanism of the sustained JunB protein 
remains unclear which might be due to some uncharacterized proteins that are 
needed to help sustain the JunB protein level (Farras et al., 2008).  
junb is a short intron-less gene of about 1.8 kb (Figure 4). The 
transcribed region is 1807 bp. The junb promoter has been studied in various 
cell types. For example, a Smad binding element (SBE) was identified in the 
- 20 - 
 
junb promoter in embryonal carcinoma cells (Jonk et al., 1998) and an 
Ets-binding site as well as a CRE-like site have been located in the junb 
promoter. These elements are reported to be responsible for the induction of 
JunB under IL-6 stimulation in hepatoma cell line HepG2 (Nakajima et al., 
1993). Besides, an enhancer region domain of around 200 bp long was 
identified to be located in approximately 200 bp downstream of the 
polyadenylation site (Salem et al., 2013). Studies have shown the importance 
of the enhancer domain in regulating junb gene transcription. NF-κB sites 
downstream of the junb gene were identified and postulated to be responsible 
for IL-6 stimulation. In murine plasmacytoma (Brown et al., 1995) as well as 
in murine macrophage cell line, RAW264.7, stimulation by LPS, induce the 
expression of JunB (Frazier-Jessen, Thompson et al.). Also, the downstream 
enhancer region was reported to be essential in cooperating with junb 
promoter by forming a chromatin loop, for regulating junb transcription under 
LPS stimulation (Salem, Gomard et al., 2013). 
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    The regulation of junb has been studied in other cells types such as 
embryonal carcinoma cells (Jonk, Itoh et al., 1998), hepatoma cell line HepG2 
(Nakajima, Kusafuka et al., 1993), murine plasmacytoma (Brown, Ades et al., 
1995) and dendritic cells (Gomard, Michaud et al., 2010). The studies of JunB 
in immune cells mainly focused on single PAMP stimulation such as LPS 
stimulation (Salem, Gomard et al., 2013) (Frazier-Jessen et al.; Fujihara et al., 
1993). Macrophages are the first to fight against invading pathogens, but the 
regulation of junb in macrophages under multiple PAMPs stimulation 
condition and how JunB contribute in immune responses remain largely 
unknown. In reality, pathogens carry multiple PAMPs, and simultaneously 
activate different TLRs, making the investigation of the regulation of junb 
under TLR pathways crosstalk great realistic significance. 
    Given the above rationale, it is important for us to investigate the 
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Chapter 2: Materials and methods 
2.1 Preparative methods 
2.1.1 Reagents 
Cell culture medium, Dulbecco's Modified Eagle Medium (DMEM), was 
purchased from Gibco, Life Techonologies (Carlsbad, CA, USA). Fetal bovine 
serum (FBS) was from Hyclone, Thermofischer Scientific (Waltham, MA, 
USA). TLR3 ligand, poly(I:C) and TLR7 ligand, R848 were purchased from 
Invivogen (San Diego, CA, USA), and recombinant mouse M-CSF was from 
Eioscience (San Diego, CA, USA). 
 
2.1.2 Depyrogenation of equipment and buffers 
Immune cells are sensitive to endotoxin /lipopolysaccharide (LPS). The 
presence of LPS will activate macrophages, interfering the interpretation of 
experimental results in macrophages. All glasswares were baked a 200
 o
C for 
at least 2 h. All cell culture equipments were treated with diversol to minimize 
endotoxin contamination. Cell culture media was prepared with pyrogen-free 
water and sterile filtered. 
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2.1.3 Animals and derivation of bone-marrow macrophages 
Eight-week old female Balb/c mice were used in the experiments. All 
experiments were performed according to the regulations and guideline of the 
Institutional Animal Care and Use Committee (IACUC protocol Ref: 049/11). 
Bone marrow derived macrophages (BMDMs) were extracted from femurs 
and tibias from 8-week old female Balb/c mice. Entire femurs and tibias were 
isolated and stored in ice-cold DMEM until used. Bones were flushed with 3 
mL DMEM per bone. The resulting cells were centrifuged at 500 g for 10 min 
at 4
 o
C. Cells were resuspended by DMEM containing 10% (V/V) FBS, 
100U/mL penicillin, 100mg/mL streptomycin and 100U/mL M-CSF at the 
density of 2×10
6 
cells /mL and plated into T75 flasks. On day 3, additional 
DMEM containing M-CSF was added and cells were cultured for another 4 
days. Experiments were carried out using the induced primary macrophages. 
 
2.1.4 Cell culture 
Murine macrophages, J774 cell line, was used in these experiments. Cells 
were cultured in DMEM containing 10% (V/V) FBS in 5% CO2 at 37
 o
C. Cells 
were gently scrapped, pipetted and plated at the density of 4×10
5 
cells/mL 
overnight in T75 flasks, T25 flasks, 12-well plates or 24-well plates according 
to specific experiments. Cells were then treated with TLR ligands over a time 
course and harvested at specific time points for investigation. The final 
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concentration of TLR ligands in this study were 10 μg/mL poly(I:C) and 25 
ng/mL R848. 
 
2.2 Analytical methods 
2.2.1 Quantitative Real-time PCR (qRT-PCR) 
J774 cells were stimulated with poly(I:C) alone, R848 alone or combination of 
poly(I:C) and R848 for certain time points as indicated. Untreated cells were 
considered as negative controls. The expression of specific mRNA was 
examined by real-time PCR. 
 
RNA extraction  
For each sample, approximately 1×10
6 
cells were resuspended and lysed in 
500 μL Trizol reagent, and stored at -80oC until RNA extraction. Samples were 
incubated at room temperature for 5 min to allow complete thaw. For each 
sample, 200 μL chloroform was added, followed by vigorous mixing for 15 s. 
Mixtures were incubated at room temperature for 2 min before being 
centrifuged at 12,000 g for 15 min at 4
o
C. The resulting aqueous phase 
containing RNA was carefully transferred into new RNase-free tubes, avoiding 
the contamination of DNA and protein from the interphase and organic phase. 
The extracted RNA was precipitated by adding 500 μL isopropanol, gently 
mixed and incubated at room temperature for 10 min. The mixture was 
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centrifuged at 12,000 g for 10 min at 4
o
C. RNA pellet was washed with 75% 
ethanol and centrifuged at 7,500 g for 5 min at 4
o
C. The supernatant was 
discarded and the RNA pellet was air-dried for 5 min and dissolved in 10 μL 
RNase-free water. The purity and integrity of RNA was analyzed by agarose 
gel electrophoresis as well as the absorbance ratios at A260/280 of NanoDrop
®
 
ND-1000 spectrophotometry.  
 
Reverse Transcription 
cDNA was synthesized using Superscript III reverse transcriptase (Invitrogen). 
The reaction contained 5 μM oligo-deoxythymidine primers, 1 mM dNTP mix, 
10 nM MgCl2, 0.02 mM DTT, 80 U RNase Out and 400U SuperScript III in a 
total volume of 10 μL. 1-2 μg of RNA extracted from cells was added to the 
reaction system. The mixture was incubated at 50
o
C for 50 min, this reaction 
was terminated by heating the mixture to 85
o
C for 5 min, then chilled at 16
o
C 
for 5 min. The resulting cDNA was diluted 10 times with DEPC-treated water 
and stored at -20
o
C until real-time PCR was performed. 
 
qRT-PCR 
SYBR Green was used in real-time PCR. SYBR Green I 
(N',N''-dimethyl-N-[4-[(E)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]-1-p
henylquinolin-1-ium-2-yl]-N-propylpropane-1,3-diamine) is a non-specific 
fluorescent dye which can bind preferentially to double-stranded DNA. The 
- 26 - 
 
DNA-dye complex absorbs blue light at 497 nm and emits green light at 520 
nm. As fluorescence signal occurs when the SYBR Green dye binds to all 
dsDNA during PCR, and increase of DNA product will lead to an increase in 
the fluorescence intensity. The rate of the amplified PCR product will be 
measured at every PCR cycle. 
Primers (Table 2) were synthesized by Integrated DNA Technologies 
(IDT) Singapore and dissolved in nuclease-free water. A primer mix for each 
gene was prepared by mixing the forward and reverse primers to a final 
concentration of 10 μM each. Primers were stored at -20oC until use. The PCR 
reaction included 5 μL LightCycler® 480 SYBR Green PCR Master Mix 
(Roche, Mannheim, Germany), 0.4 μL primer mix, 1 μL diluted cDNA and 3.6 
μL nuclease-free water to a total volume of 10 μL. Three replicates were made 
for each sample. To ensure uniformity, master mix was prepared. All the 
real-time PCR reactions were performed using LightCycler
®
 480 II system 
(Roche, Mannheim, Germany). junb mRNA level was normalized to gapdh. 
The specificity of PCR products were confirmed by analysis of melting 
temperature (Tm) curve (single peak). The thermocycling protocol was: a hot 
start of 95
o
C for 10 min, followed by 40 cycles of 95
o
C for 10 s and 60
o
C for 
15 s. Fluorescence signals were measured during each annealing step. Data 
were collected for analysis at the end of PCR. 
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Table 2. The primers for qPCR 
Name Sequence 
junb F CAGCTACTTTTCGGGTCAGG 
junb R ACGTGGTTCATCTTGTGCAG 
gapdh F TGCACCACCAACTGCTTAG 
gapdh R GGATGCAGGGATGATGTTC 
 
2.2.2 Western Blot analysis 
Cell lysis 
Cell culture media were removed from J774 cells which were transfected 
using X-tremeGENE HP DNA Transfection Reagent together with or without 
plasmid DNA, followed by NT, I, R or IR stimulations for 5 h, and cells were 
washed with ice cold PBS. Approximately 1×10
6 
cells per sample were lysed 
in RIPA buffer (50 mM Tris-HCl pH7.5, 0.5% deoxycholate, 150 mM NaCl, 1% 
NP40, 0.1% SDS, 1 mM EDTA) containing a cocktail of proteinase inhibitor 
for 20 min on ice. Cell lysates were centrifuged at 16,000 g for 15 min at 4
o
C. 
Supernatants were collected and stored at -80
o
C before use.  
 
Nuclear isolation 
Cell culture media from J774 cells or BMDM treated with NT, I, R or IR 
stimulations for indicated time points in specific experiments were removed. 
Cells were washed with ice cold PBS and centrifuged at 500g for 10 min at 
4
o
C, and resuspended in Basic Lysis Buffer (15 mM NaCl, 60 mM KCl, 10 
mM Tris-HCl pH8, 3 mM MgCl2, 1 mM EDTA, 1 mM DTT, 0.5 mM 
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spermidine, 0.15 mM spermine) containing a cocktail of proteinase inhibitor. 
The volume of Basic Lysis Buffer added was 5× of the volume of cell pellet. 
An equal volume of Working Lysis Buffer (15 mM NaCl, 60 mM KCl, 10 mM 
Tris-HCl pH8, 3 mM MgCl2, 1 mM EDTA, 1 mM DTT, 0.5 mM spermidine, 
0.15 mM spermine, 0.15% NP40) containing a cocktail of proteinase inhibitor 
was added and the reaction mixture was gently mixed. Mixtures were 
incubated for 2 min on ice before centrifugation at 14,000 g for 15 s at 4
o
C. 
Supernatant was removed and nuclear pellet was washed 2 times with Basic 
Lysis Buffer using 10× the volume of nuclear pellet, then centrifuged at 9,000 
g for 15 s at 4
o
C. During the second washing, 10 μL of nuclear suspension was 
mixed with 10 μL Trypan Blue Stain to confirm the efficiency of nuclear 
isolation. Trypan Blue is a vital dye which stains dead cells. Since Trypan 
Blue can not stain live cells with intact membrane, we can ensure of cell lysis. 
All cell should been lysed and nucleus stained blue. Nuclear pellet was stored 
at -80
o
C until analysis. 
 
Nuclear lysis and nuclear extraction 
For nuclear lysis, the isolated nucleus were thawed on ice for 10 min. Nuclear 
were lysed in RIPA buffer for 20 min on ice. Nuclear lysates were centrifuged 
at 16,000 g for 15 min at 4
o




For nuclear isolation, the isolated nucleus were gently resuspended using 
- 29 - 
 
Nuclear Extract Buffer (20 mM Tris-HCl pH8, 420 mM NaCl, 1.5 mM MgCl2, 
0.2 mM EDTA, 25% (V/V) glycerol, 0.5 mM spermidine, 0.15 mM spermine) 
containing a cocktail of proteinase inhibitor. The buffer volume added was 4× 
that of nuclear pellet. The mixture was incubated on ice for 1 h, with vortexing 
every 10 min, followed by centrifugation at 20,000 g for 20 min at 4
o
C. 
Supernatants were collected and stored at -80
o
C until used. 
 
Protein quantitation 
The protein concentration of the resulting supernatant from cell lysis, nuclear 
lysis and nuclear extraction was quantified by Bradford assay. To determine 
the protein concentration, a standard curve was generated using 5, 2.5, 1.25, 
0.625 and 0.3125 μg/mL BSA. The calibration curve was used as a standard 
for protein concentration calculation. Protein samples were diluted 1:50 in 
water. 200 μL of Bradford Dye (Biorad) was added to 10 μL diluted protein 
samples and a serial dilution of known concentrations of BSA. After 
incubation for 5 min at room temperature, the protein concentration was 
measured by absorbance of 595 nm using a BioTek plate reader. For each 
sample, triplicate readings were obtained and calculated. 
 
SDS-PAGE and immunoblotting 
Protein samples were diluted in SDS loading buffer (1 M Tris-HCl pH8, 50% 
(v/v) glycerol, 10% w/v SDS, 1% w/v bromophenol blue, β-mercaptoethenol) 
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and boiled at 98
oC for 10 min. 10 μg protein was resolved on 12% SDS-PAGE 
and electro-transferred to a PVDF membrane using semi-dry transfer method 
for 1 h at 10 V and 350 mA. The membrane was blocked with 5% skimmed 
milk in TBST (50 mM Tris-base, 150 mM NaCl, 0.01% Tween-20, pH7.6) for 
1 h. Primary antibodies (Table 3) were diluted in 1% skimmed milk in TBST. 
Membranes were incubated with protein target-specific primary antibodies 
overnight at 4
o
C with gentle agitation. Membranes were then washed three 
times with TBST, for 5 min each. Next, the membranes were incubated with 
HRP-conjugated secondary antibodies diluted in 1% skimmed milk TBST 
(1:5000) for 1 h in room temperature and washed three times with TBST. The 
signals of the protein of interest was detected by incubating the membranes 
with SuperSignal West Pico enhanced chemiluminescent (ECL) substrate 
(Thermo Scientific) for 1 min, followed by digital imaging using ImageQuant 
LAS 4000 mini (GE Healthcare Life Sciences). To ensure uniformity, equal 
amounts of protein was loaded and determined by comparison with the 
amount of GAPDH protein. Membranes were stripped with Restore Western 
Blot Stripping Buffer (Thermo Scientific) by incubating 30 min at 37
o
C with 
gentle agitation for sequential antibody probing, followed by three washes 
with TBST. To probe the same membranes with different antibodies, the 
stripped membranes were blocked again with 5% skimmed milk TBST and 
incubated with new primary antibodies. 
    The antibodies used in this thesis work are listed in Table 3. 
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Table 3. The list of antibodies 
Primary antibodies 
Name Source  Company 
JunB Rabbit Santa Cruz Biotechnology 
TBP Mouse Abcam 
IRF1 Rabbit Santa Cruz Biotechnology 
GAPDH Mouse Santa Cruz Biotechnology 
AATF Rabbit Abcam 
SSRP1 Rabbit Santa Cruz Biotechnology 
TARDBP Rabbit Pierce Thermo Scientific 
Secondary antibodies 
Anti-mouse-HRP Goat Dako 
Anti-rabbit-HRP  Goat Dako 
Anti-goat-HRP Rabbit Dako 
 
2.2.3 Molecular cloning of junb promoter, enhancer and 3’UTR 
Genomic DNA extraction 
Approximately 1×10
6
 J774 cells or 4×10
6
 mice bone marrow derived 
macrophages (BMDM) were used for genomic DNA extraction. Nuclear 
isolation was as described above in the Nuclear isolation step. 500 μL Trizol 
Reagent was added to each nuclear sample, fully resuspended and incubated at 
room temperature for 5 min. 100 μL chloroform-isoamyl alcohol 
(chloroform:isoamyl alcohol=24:1 (V/V)) was added. The mixture was 
vortexed briefly and incubated at room temperature for 5 min, followed by 
centrifugation at 12,000 g for 15 min at 4
o
C. Water phase was removed, 150 
μL ethanol was added, mixed by inversion and incubated at room temperature 
for 5 min. Mixture was centrifuged at 2,000 g for 5 min at 4
o
C. DNA pellet 
was washed with 500 μL 0.1M sodium citrate 10% ethanol twice, each time 
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with an incubation time of 20 min at room temperature. DNA pellet was air 
dried and resuspended in 100 μL 8mM NaOH, stored at -20oC before use. 
 
Polymerase chain reaction (PCR) 
Polymerase chain reaction was performed using iProof
TM
 High-Fidelity DNA 
Polymerase. The reaction system included 10 μL 5× iProof HF Buffer, 1 μL 10 
mM dNTP mix, 2.5 μL forward and reverse primers each, 0.5 μL iProof DNA 
polymerase and sterile water in a total volume of 50 μL. The amount of DNA 
template used was 250 ng genomic DNA or 150 ng plasmid DNA. Primers 
used were listed before in Table 4. The thermocycling protocol was: an initial 
denaturation start of 98
o
C for 30 s, followed by 34 cycles of 98
o
C for 10 s, 
annealing temperature (Tm) for 30 s, extension at 72
o
C at a rate of 1 kb/min 
for Taq polymerase (New England Biolabs) and 2 kb/min for iProof
TM
 
High-Fidelity DNA polymerase (Biorad) (the extension time was set according 
to the length of target DNA fragment) and a final extension at 72
o
C for 10 min 
then end at 16
o
C. The resulting PCR products were separated on 1% agarose 
gel containing 0.0075% (V/V) SYBR Safe and confirmed by using purified 
using Wizard
®
 SV Gel and PCR Clean-up System Kit (Promega) according to 
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Table 4. List of primers in cloning 
Name sequence comment 
2kb junb 
promoter 
5’GGGCCCGCAGCTACCTCGAGTTCCT 3’ ApaI site 
5’ CGAGCTC GTGGAGGCTAGCTTCAGAG 3’ SacI site 
luciferase reporter assay 
1793bp junb pro 
luc4.2 
5’ GCAGCTACCTCGAGTTCCT 3’ XhoI site 
5’ CCGCTCGAGATCTGGGAAAGGTCCC CCT 3’ XhoI site 
1328bp junb pro 
luc4.2 
5’ CCGCTCGAGTTCCCTAGCCTGTTTCTA AGG 
3’ 
XhoI site 
5’ CCGCTCGAGATCTGGGAAAGGTCCC CCT 3’ XhoI site 
790bp junb pro 
luc4.2 
5’ CCGCTCGAGTTCCTCCCAACTGACAA TTC 3’ XhoI site 
5’ CCGCTCGAGATCTGGGAAAGGTCCC CCT 3’ XhoI site 
324bp junb pro 
luc4.2 
5’ CCGCTCGAGTTCCGCAGCTGACAAATT 3’ XhoI site 
5’ CCGCTCGAGATCTGGGAAAGGTCCC CCT 3’ XhoI site 
1793bp junb pro
 luc3 
5’ CGAGCTCGCAGCTACCTCGAGTTCCT 3’ SacI site 
5’ CGAGCTCATCTGGGAAAGGTCCCCCT 3’ SacI site 
proximal junb 
pro luc3  
5’ CGAGCTCTGACCTCCCCAAAATTCCTT 3’ SacI site 
5’ CGAGCTCCACCCTCAAAGTCCCCAGT 3’ SacI site 
junb 3'UTR 
luc3 
5’ ACGCGTCGACTTGCCCCATACGGAC ACC 3’ SalI site 
5’ ACGCGTCGACATGGCTCCCAGGGCT CAT 3’ SalI site 
 
Restriction enzyme digestion and ligation 
The purified DNA fragments and the chosen backbone vectors, pGEMT-easy, 
pGL4.2, or pGL3-Basic, were digested with specific restriction enzymes for 6 
h in 37
o
C (the cutting sites of the chosen restriction enzymes were added to 5' 
end of the primers), and were cleaned up again as described before. T4 ligase 
(Roche) was used for the ligation of digested backbone vector and DNA 
fragment overnight at 4
oC. Ligation system was 2.5 μL 10× T4 DNA ligase 
buffer, 50 ng backbone vector, an amount of DNA fragment 5× that of 
backbone vector (using the equation: (kb size of insert × 5)/(kb size of vector 
× 1)= (ng insert)/(ng vector)), 2.5 μL T4 ligase and steriled water top up to a 
total volume of 25 μL.  
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Transformation of junb promoter subclones into E. coli 
100 μL of E.coli DH5α competent cells were thawed on ice for 10 min. The 
ligation mixture was added into the competent cells with gentle pipetting and 
incubated for 20 min on ice. The transformed E. coli were then heat-shocked 
for 1 min at 42
o
C followed by immediate chill on ice for 2 min. 900 μL LB 
broth without antibiotics was added into the competent cells and incubated for 
1 h at 37
oC for cells to recover. 100 μL of the mixture was spread out onto 
freshly dried LB agar plate containing 100 μg/mL ampicillin. The LB plate 
was incubated upside-down overnight at 37
o
C and examined for the presence 
of ampicillin-resistant colonies. 
 
Colony PCR and plasmid amplification 
Colony PCR was performed when single colonies were present on LB plate 1. 
The reaction system included 1 μL 10× Taq DNA polymerase buffer, 0.2 μL 10 
μM forward and reverse primers (on backbone vectors), 0.2 μL 10 mM dNTP 
mix, 0.1 μL Taq polymerase and sterile water to top up to a total volume of 10 
μL. Bacteria served as template in this reaction. Single colony was picked 
from the LB plate 1 using a pipette tip, gently inoculated onto another LB 
plate 2 and marked for future reference. This pipette tip was dipped into the 
PCR mixture for 2 min to let the bacteria enter the reaction system. The 
thermocycling protocol was an initial denaturation start of 95
o
C for 5 min, 
followed by 34 cycles of 92
o
C for 20 s, annealing temperature (Tm) for 20 s, 




C for certain time (according to the length of target DNA 
fragment) and a final extension at 72
o
C for 10 min then end at 16
o
C. The 
resulting PCR products were analyzed by separating on 1% agarose gel, 
followed by imaging using Gene Genius from SynGene. The products which 
showed the DNA bands of correct size were potential clones that contained 
insertions. These clones were picked correspondingly from LB plate 2 and 
cultured in 5 mL LB broth containing ampicillin for plasmid miniprep and 100 
mL LB broth containing ampicillin for plasmid midiprep overnight at 37
o
C 
with shaking at 250 rpm. Plasmid miniprep isolation was performed using 
AxyPrep
TM
 Plasmid Miniprep Kit (Fisher Scientific) and midiprep using 
PureLink
TM
 Hipure Plasmid Filter Midiprep Kit (Invitrogen by life 
technologies) according to the manufacturer’s protocol. The resulting plasmids 
were used for DNA sequencing. 
 
DNA sequencing 
Plasmid DNA sequencing used the ABI PRISM BigDye terminator cycle 
sequencing technology. Sequencing is based on the random incorporation of 
ddNTP into a growing DNA chain by Taq polymerase from Thermus 
aquaticus. ddNTPs are called dideoxynucleoside triphosphates, which lack the 
3' hydroxyl group on the ribose sugar moiety of the nucleotide, thus ddNTPs 
block the formation of the next phosphodiester bond and act as chain 
terminators. Four sets of dideoxy terminators labeled with 4 high-sensitivity 
- 36 - 
 
fluorescence dyes, each emits its fluorescence at a different wavelength. The 
Taq polymerase used contains two mutations, which allow the enzyme to 
incorporate dNTP and ddNTP dye terminators with equal efficiency.  
The sequencing PCR reaction system included 1 μL 5× sequencing buffer, 
approximately 150 ng plasmid DNA, 1.6 μL 1 μM primer, 2 μL Big Dye and 
3.4 μL sterile water. The thermocycling protocol involved a hot start of 95oC 
for 5 min, followed by 35 cycles of 95
o
C for 30 s, 50
o
C for 10s and 60
o
C for 4 
min, and finally hold at 16
oC. 40 μL of Precipitation Mix (7.25 μL sterile 
water, 1.5 μL 3M NaOAc pH5.2, 31.25 μL 95% ethanol) was added into the 
PCR mixture. The mixture was vortexed briefly and incubated at room 
temperature for 15 min, followed by centrifuging at 14,000 g for 20 min at 4
o
C. 
Sample pellet was washed with 700 μL 70% ethanol and centrifuged at 15,000 
g for 5 min, dried by using Centrifugal Vaporizer CVE-100D (Fisher General 
Scientific). Sample pellet was resuspended with 15 μL HI DI formamide, fully 
vortexed and centrifuged to collect the contents. The contents were transferred 
into a 96 well microtiterplate. Sequencing electrophoresis started using ABI 
PRISM 3100 DNA Sequencer. Data were retrieved from computer for analysis. 
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Preparation of the NF-κB mutant clones 
Synthesized DNA fragments were prepared by Optimal Biotechnologies in 
pUC53 plasmid using SalI restriction enzyme sites. 50 ng of the 
pUC53+mutated 3'UTR were transformed into E.coli DH5α competent cells as 
described before. Single clones were picked and sub-cultured overnight in 
aliquots of 5 mL LB broth. Plasmids were digested using SalI, ligated with 
SalI digested pGL3+long promoter or pGL3+short promoter plasmid. After 
transformation and sequencing, the correct clones were used for dual 
luciferase assay. 
 
Sequences of the NF-κB mutants: 
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The four NF-κB sites are highlighted in red. 
The sites mutated were highlighted in yellow. 
All sequences were synthesized by Optimal Biotechnologies. 
 
Pyrogen-free plasmid preparation (for transfection) 
All plasmids used for cell transfection should be endotoxin-free. Endotoxin 
are cell membrane components of Gram-negative bacteria, also known as LPS. 
During the lysis of bacteria for plasmids preparation, large amount of 
endotoxin was released by bacteria cells. To get rid of the endotoxin 
contamination to macrophages during transfection, endotoxin should be 
strictly removed. Single clones were cultured in 100 mL LB broth with 250 
rpm shaking in 37
 o
C overnight. Plasmids were extracted using PureLink
TM
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Hipure Plasmid Filter Midiprep Kit (Life Technologies) according to the 
manufacturer’s protocol. 
 
2.2.4 Dual luciferase reporter assay 
Transfection  
J774 cells were plated at a density of 4×10
5 
cells/mL overnight in 24-well 
plate. Transfection was performed using X-tremeGENE HP DNA Transfection 
Reagent (Roche) according to the manufacturer’s protocol. Briefly, 
X-tremeGENE Transfection Reagent, DNA and DMEM were equilibrated at 
room temperature for 10 min. X-tremeGENE were vortexed briefly before use. 
A total amount of 1.3 μg plasmid DNA ((amount of firefly luciferase 
constructs):(renilla luciferase vector(CMV))=40:1) and 1.6 μL X-tremeGENE 
Transfection Reagent were diluted in DMEM in a total volume of 100 μL. The 
transfection reagent-DNA complex were mixed gently and incubated for 30 
min at room temperature. 50 μL of the mixture was added to the cells in a 
dropwise manner to ensure even distribution. Cells were incubated for 24 h in 
5% CO2 at 37
oC, and then stimulated with 10 μg/mL Poly(I:C), 25 ng/mL 
R848, 10 μg/mL Poly(I:C) and 25 ng/mL R848 (referred to as combinatorial or 
simultaneous stimulation: "IR"). Cells were collected at 3 h post-stimulation 
for dual luciferase reporter assay analysis and at 5 h post-stimulation for cell 
lysis and Western blot analysis as previously described. 
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Dual luciferase reporter assay 
Dual luciferase reporter assay was performed to monitor the activity of the 
junb promoter subclones. Dual-Luciferase® Reporter Assay Kit (Promega) 
was employed and the assay was performed according to the manufacturer’s 
protocol. Cell culture media was removed by aspiration. Cells were washed 
with 500 μL PBS per well and lysed with 80 μL Passive Lysis Buffer, shaken 
at 400 rpm on an orbital shaker for 15 min. Luminescent signals were 
measured by DLR-INJ-0 Promega protocol on Glomax luminometer (2 s 
pre-measurement delay followed by 10 s measurement period for each 
reporter). 5 μL cell lysis was added into 25 μL LARII buffer and mixed well. 
Firefly luciferase reading was initiated in the luminometer, followed by 
addition of 25 μL StopGlo reagent and the measurement of renilla luciferae 
reading. For each sample was measured in triplicates. Data was obtained for 
further analysis. 
 
2.2.5 DNA-protein interaction analysis 
Biotin-labeling of DNA probes 
DNA fragments were labeled with biotin using the DNA 3' end biotinylation 
kit (Pierce). DNA fragments of interest were amplified using PCR from 
constructed plasmids as described before. In order to enable 3' overhang for 
biotin labeling, specific restriction enzymes which provide DNA 3' OH ends 
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were added on both sides of the primers (Table 5). DNA fragment were 
digested with corresponding restriction enzymes and purified as described 
previously. 5 pmol DNA 3' OH ends, which equalled 2.5 pmol DNA, was used 
in each biotin-labeling reaction. The standard reaction included 10 μL 5× TdT 
buffer, 2.5 pmol digested DNA fragments, 5 μL Biotin-11-UTP, 20 U TdT 
enzyme and steriled water in a total volume of 50 μL. The mixture was 
incubated at 37
o
C for 1 h and inactivated by addition of 1 μL 0.5 M EDTA. 
Biotin-labeled DNA fragments were purified as described previously. Probes 
were diluted 4 times for following electrophoretic mobility shift assays 
(EMSA) experiment. 
 
Table 5. Primers for biotin labeled probes 
biotin labeled DNA 
Name Sequence Comment 
1598bp junb 
promoter 
5’ GGGCCCTTCCCTAGCCTGTTTCTAAGG 3’ ApaI site 
5’ CGAGCTC GTGGAGGCTAGCTTCAGAG 3’ SacI site 
1060bp junb 
promoter 
5’ GGGCCCTTCCTCCCAACTGACAATTC 3’ ApaI site 
5’ CGAGCTC GTGGAGGCTAGCTTCAGAG 3’ SacI site 
594bp junb 
promoter 
5’ GGGCCCTTCCGCAGCTGACAAATT 3’ ApaI site 
5’ CGAGCTC GTGGAGGCTAGCTTCAGAG 3’ SacI site 
junb 3'UTR  5’ CGAGCTCTTGCCCCATACGGACACC 3’  SacI site 
5’ CGAGCTCATGGCTCCCAGGGCTCAT 3’  
SacI site 
 
Electrophoretic mobility shift assay (EMSA) 
Electrophoretic mobility shift assays (EMSA) were conducted using 
LightShift EMSA Optimization and control kit (Pierce). The binding reaction 
included 2 μL 10× binding buffer (100 mM Tris pH7.5, 500 mM KCl, 10 mM 
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DTT), 3 μL 50% glycerol, 1 μL poly(dI:dC), 1 μL 1% NP40, 7 μL steriled 
water, 5 μL nuclear extract and 1 μL diluted biotin-labeled probes (added last). 
The mixture was incubated in 25
o
C for 30 min and resolved on 1% agarose gel 





 GE Healthcare) in 
TAE buffer (4.84 g Tris Base, 1.142 mL glacial acetic acid, 2 mL 0.5 M EDTA 
and water topped up to a total volume of 1 L) at 350 mA for 1 h 20 min. The 
membrane was cross-linked using OPTIMAL CROSSLINK of Spectrolinker 
XL-1000 UV Crosslinker and washed with PBSS (PBS:10% SDS=1:1 (V/V)) 
for 5 min at room temperature with gentle agitation. The membrane was 
incubated with the specific HRP-conjugated Streptavidin antibody diluted in 
PBSS (1:5000) for 15 min in room temperature and washed three times for 10 
min each with PBST, and once with PBS for 10 min. Biotin signal was 
detected by incubating membranes with SuperSignal West Pico enhanced 
chemiluminescent (ECL) substrate (Thermo Scientific) for 1 min, followed by 
digital imaging using ImageQuan t LAS 4000 mini (GE Healthcare Life 
Sciences). 
Co-Shift  
The experimental procedure was the same as in the EMSA experiment, except 
the binding reaction system which included both promoter probes and 
enhancer probes (1:1), and the agarose gel was run in TBE buffer (0.22 M Tris, 
150 mM Borate, 5 mM EDTA, pH8.3) instead.  
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Pulldown assay 
Pulldown assay was performed using Dynabeads kilobase BINDER kit 
(Invitrogen). Biotin-labeled probes were incubated with nuclear extract 
proteins. The DNA-protein binding reaction system was the same as in the 
EMSA experiment, except that the total reaction volume was increased to 100 
μL.  
The magnetic beads were washed twice with washing buffer (10 mM Tris-HCl 
pH7.4, 50 mM KCl, 80 mM NaCl, 2 mM MgCl2, 12.5% glycerol and 0.05% 
NP40). The whole DNA-protein binding sample was added into the magnetic 
beads gently, and incubated in 4
o
C for 3 h with gentle rotation. The 
supernatant was removed and the beads were gently washed with washing 
buffer and boiled in Tricine loading buffer (1 mL 1M Tris-HCl pH6.8, 80 μL 
10% SDS, 2.4 mL glycerol, 0.8 g SDS and 0.31 g DTT, Coommassie Blue 
6250 in a total volume of 10 mL) at 98
o
C for 10 min. Samples were stored at 
-80
o
C until used. 
 
Silver staining of PAGE gel 
Pulldown samples were resolved in Tricine-SDS-PAGE. The concentration of 
the separating gel used was 12 % (4 mL 30% Acryl/Bis, 3.3 mL Tris-HCl/SDS, 
1.7 mL sterile water, 1 mL glycerol, 50 μL 10% APS and 10 μL TEMED) and 
stacking gel 4% (0.52 mL 30% Acryl/Bis, 1 mL Tris-HCl/SDS, 2.4 mL sterile 
water, 50 μL 10% APS and 5 μL TEMED). Electrophoretic buffers used were 
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anode buffer (24.3 g Tris topped up to 1 L with water, pH 8.9) and cathode 
buffer (12.11 g Tris, 17.92 g Tricine, 1 g SDS topped up to 1 L with water). 
Electrophoresis was performed at 30 V until the samples completely entered 
the stacking gel, 190 V for proteins to separate and at 270 V approaching the 
end of the run to shorten the time of electrophoresis.  
The gel was fixed in 50% methanol, 5% acetic acid and 45% sterile water, for 
20 min with gentle agitation, washed three times for more than 20 min each 
with MilliQ water. Then gel was sensitized in 0.02% sodium thiosulfate at 
room temperature for 2 min and immediately washed twice for 1 min each 
with MilliQ water. The sensitized gel was incubated in 0.1% silver nitrate in 
darkness at 4
o
C for 20 min with gentle agitation, washed twice for 1 min each 
with MilliQ water. The gel was transferred into a clean tray for development 
using 2% sodium carbonate and 0.04% formaldehyde until clear bands turned 
out in the gel. The solution was removed and the gel was rinsed with MilliQ 
water for storage. 
 
Co-pulldown assay 
The procedure of co-pulldown is similar to the pulldown assay described 
above, but with larger reaction scale and with both junb promoter and 
enhancer as probes. Co-pulldown assay was performed using Dynabeads 
kilobase BINDER kit (Invitrogen). Two kinds of biotin-labeled probes were 
incubated with nuclear extract proteins. The DNA-protein binding reaction 
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system was the same as in the EMSA experiment, except that the total reaction 
volume was increased to 100 μL for SDS-PAGE analysis and 600 μL for mass 
spectrometry analysis. The whole DNA-protein binding sample was added 
into the washed magnetic beads, and incubated in 4
o
C for 3 h with gentle 
rotation. The mixture were centrifuged at 500 g for 5 min in 4
o
C, and stood on 
magnetic stand for 2 min. The supernatant was removed and 1% formaldehyde 
in PBS was added into the beads to fix the protein complex bound to the probe 
on the beads, for 15 min. The mixture was placed on the magnetic stand for 2 
min and the supernatant was removed. 0.1 M glycine in PBS-Triton X-100 
(0.5%) was added for 5 min to quench the formaldehyde. Beads were washed 
with PBS-Triton (0.5%) twice followed by PBS twice before boiling in SDS 
loading buffer at 98
o
C for 20 min to condense the protein samples. Samples 
were stored at -80
o
C until used for analysis. 
 
Silver blue staining of PAGE gel 
The co-pulldown protein samples were resolved in three-layer SDS PAGE gel 
(from top to bottom: 4% stacking gel, 10% separating gel, 25% separating gel). 
Electrophoresis was stopped when the proteins have all entered the 10% gel 
layer. The gel was fixed in Fixer (50% ethanol, 1.18 mL 85% H3PO4 and 23.8 
mL MilliQ water in a total volume of 50 mL) for 1 h with gentle agitation, 
washed with MilliQ water three times for >20 min each. Silver blue staining 
solution (100 g ammonium sulphate, 1.2 g Coomassie Blue G-250, phosphoric 
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acid (final concentration 10%), 200 mL methanol, Milli-Q water up to 1 L) 
was added to the gel and gently agitated overnight. The solution was removed 
and the gel was rinsed with MilliQ water three times for 20 min each. The gel 
was scanned and then subjected to preparation for mass spectrometry analysis. 
 
2.2.6 Mass spectrometry 
Gel washing 
Gel with proteins was cut into 1 mm×1 mm cubes and collected into Protein 
LoBind Tube (EPPENDORF TUBES
®
). Gels were washed with MilliQ water 
twice and shaken with ThermoMixer C at 1200 rpm for 15 min. 100 mM 
ammonium bicarbonate with 50% methanol was added to the gels and gently 
agitated for 15 min. Gels were washed three times sequentially with 50 mM 
ammonium bicarbonate for 5 min, 50 mM ammonium bicarbonate with 50% 
acetonitrile for 15 min, 100% acetonitrile for 5 min. Gels were then dried by 
SpeedVac vacuum and stored at -20
 o
C until reduction and alkylation.  
 
Reduction and alkylation 
10 mM dithiothreitol in 100 mM ammonium bicarbonate were added to gels 
from washing step at 37
 o
C for 1 h. The supernatant was removed and 55 mM 
iodoacetamide in 100 mM ammonium bicarbonate was added, and the gels 
were incubated in darkness at room temperature for 30 min. After removing 
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the supernatant, the following sequential reactions were performed: 20 mM 
ammonium bicarbonate was added for 15 min with shaking, 20 mM 
ammonium bicarbonate in 50% acetonitrile for 15 min with shaking, and 100% 
acetonitrile for 5 min with shaking. The supernatant was removed between  





Gels were rehydrated on ice with the trypsin- ammonium bicarbonate solution 
(25 mM ammonium bicarbonate, 6 ng/μL trypsin and 1 mM CaCl2) for 1.5 h. 
The remaining trypsin-ammonium bicarbonate solution was removed. To 
cover the gels completely, 25 mM ammonium bicarbonate with 1 mM CaCl2 
was added. The gels together with the solution were incubated at 37
 o
C 
overnight. Mixture was centrifuged at 6000 g for 5 min. The trypsin digestion 
process was stopped by adding 2% formic acid with shaking for 10 min. 
Mixture was spinned down briefly at 6000 g. Supernatant containing peptides 
was transferred to clean Protein LoBind tubes. To ensure complete wash out of 
peptides from gels, gels were washed sequentially with 5% formic acid with 
shaking for 10 min, 5% formic acid in 50% acetonitrile with shaking for 10 
min twice, 100% acetonitrile with shaking for 10 min. Supernatant containing 
peptides of each step was retrieved and combined together. Peptides were 
obtained by drying the supernatant using SpeedVac vacuum. The dried 
peptides were stored at -20
o
C .  
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Desalting 
Dried peptides were dissolved in 0.5% trifluoroacetic acid. Protein desalting 
was performed using C-18 Spin columns (Thermo Scientific). C18 Spin 
columns were activated with 100% acetonitrile and equilibrate with 0.5% 
trifluoroacetic acid in 2.5% acetonitrile. 2.5% acetonitrile was added into the 
equilibrated column just before loading the sample. Protein sample with 
acetonitrile was incubated for 5 min before centrifugation at 1500 g for 1 min. 
Columns were washed twice with 0.5% trifluoroacetic acid. Proteins were 
eluted with 50%, 70% and 100% acetonitrile sequentially. The eluted sample 
was dried by SpeedVac vacuum and stored at -20
 o




Mass spectrometry was performed using AB SCIEX Triple-TOF 5600 at the 
Protein and Proteomics Centre, National University of Singapore. 
 
2.3 In vitro treatments of J774 cells 
2.3.1 Inhibition of new mRNA synthesis by actinomycin D treatment 
To investigate the post-transcriptional regulation of junb mRNA, the stability 
of junb mRNA was analyzed using actinomycin D because actinomycin D 
arrests RNA synthesis and transcription. J774 cells were plated at a density of 




cells/mL overnight in a 24-well plate. Cells were then stimulated with 
10 μg/mL Poly(I:C), 25 ng/mL R848, 10 μg/mL Poly(I:C) and 25 ng/mL R848 
(simultaneously "IR") for 1 h. 10 μg/mL of mRNA transcription inhibitor, 
actinomycin D, was added to the cells. RNA was extracted at indicated time 
points post-actinomycin D treatment by Trizol as previously described. 
 
2.3.2 Inhibition of new protein synthesis by cycloheximide treatment 
To investigate the post-translational regulation of JunB protein, the stability of 
JunB protein was analyzed by using cycloheximide (CHX)(Sigma). CHX 
inhibits protein translation, thus blocking new protein synthesis. J774 cells 
were plated at a density of 4×10
5 
cells/mL overnight in 24 well plate. Cells 
were then stimulated with 10 μg/mL Poly(I:C), 25 ng/mL R848, 10 μg/mL  
Poly(I:C) and 25 ng/mL R848 (simultaneously "IR") for 8 h. 10 μg/mL of 
protein synthesis inhibitor CHX was added to the cells. The nucleus was 
isolated and lysed at indicated time points post-CHX treatment, followed by 
Western blot analysis as previously described (see section 2.2.2). 
 
2.4 Bioinformatics analysis 
Putative transcription factors binding sites were analyzed using softwares: 
TFsearch(http://www.cbrc.jp/research/db/TFSEARCH.html); 
Alibaba2(www.gene-regulation.com).  
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The evolutionarily conserved regions were predicted by ECR Browser 
(http://ecrbrowser.dcode.org/). 
 
2.5 Statistical analyses 
Data were achieved in three independent experiments, three replicates per 
sample or condion, and presented as means with standard deviation. Statistical 
significance was calculated using two-tailed Student's t-test, and p<0.05 was 
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Chapter 3: Results 
3.1 junb mRNA and JunB protein were induced in murine macrophages 
under PAMPs stimulations 
From our lab’s recent efforts, we found JunB to be a potential synergy 
factor (Liu, Zhu et al., 2015). By knocking down junb the proinflammatory 
cytokine synergy was impaired (Liu, Zhu et al., 2015). This led us to 
hypothesize that JunB may have important roles in regulating and/or 
integrating immune responses, culminating in the synergy effect. 
It has been reported that under LPS stimulation, the expression level of 
JunB is induced in mouse macrophages (Frazier-Jessen, Thompson et al.; 
Fujihara, Muroi et al., 1993). However, little is known about the expression 
pattern of JunB under stimulations by single PAMP (polyI:C or R848) and 
combinatorial PAMPs (for example, polyI:C and R848). Hence, in this thesis, 
we first sought to confirm the induced expression profiles of JunB in 
macrophages, both at the transcriptional and translational levels. By studying 
these patterns, we may have a basic idea on which TLR-mediated pathway 
induces JunB, namely inquiring the TLR3 and TLR7 pathways, and whether 
JunB undergoes post-transcriptional or post-translational regulations. 
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3.1.1 junb mRNA was induced in murine macrophages under PAMPs 
stimulations 
    Both junb mRNA and JunB protein were found to be induced upon LPS 
stimulation in macrophage-like cell lines, J774 and RAW264.7, and bone 
marrow-derived DCs (Frazier-Jessen, Thompson et al.; Fujihara, Muroi et al., 
1993) (Gomard, Michaud et al., 2010). Here, we first surveyed whether junb 
mRNA is induced upon TLR3 stimulation by poly(I:C) and/or TLR7 
stimulation by R848 in J774 cells. A time course study in junb mRNA 
production was performed in J774 cells induced by single PAMP (I or R) or 
combinatorial PAMP (IR) stimulations using real-time PCR. Cells were 
stimulated and harvested in 0, 0.5, 1, 2, 4, 8, 12, 24 h. Figure 5 (a) shows that 
junb mRNA was induced upon I, R and IR stimulations over 24 h. While I 
induced junb mRNA, R stimulated higher levels of junb, and IR 
co-stimulation further enhanced the transcription. The transcription of junb 
mRNA peak at 2 h under I stimulation and 1 h under R or IR stimulations. In I 
stimulation, junb mRNA died down by 4 h, while the mRNA level sustained 
longer in R and IR stimulations. A junb mRNA prolonged peak was observed 
over 10 h to 24 h under IR stimulation.  




Figure 5. Expression of JunB in J774 cells. J774 cells were treated with either 
10 μg/ml poly(I:C) (I), 25 ng/ml R848 (R) or combinatorial PAMP (IR). Cells 
were harvested at the indicated time points. (a) junb mRNA level was 
determined by using real-time PCR with gapdh as internal control. As 
induction of junb mRNA peaks at different times from 1 to 2 h 
post-stimulation, depending on the passage number of J774 cells, no error bars 
are presented as this is a representative result from 3 independent experiments. 
(b) Nuclear lysates were resolved on SDS-PAGE gel, transferred to PVDF 
membrane and probed with antibodies against JunB and TATA-binding protein 
(TBP) (internal control). 
 
3.1.2 JunB protein was induced in murine macrophages under PAMPs 
stimulations 
   Next, we tested whether JunB protein undergoes induction in J774 cells 
under I, R and IR stimulations. A timecourse experiment with the same time 
points as in 3.1.1 was carried out and JunB from whole cell lysis was analyzed 
(b) 
(a) 
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using Western Blot. Figure 5 (b) shows that JunB protein was induced upon I, 
R and IR stimulations over 24 h. In each stimulation time point, the expression 
pattern of JunB protein shows a slight induction under I stimulation, higher in 
R and a further enhancement in IR co-stimulation. The expression of JunB 
protein peaks from 4 h up to 12 h under I, R and IR stimulations. Figure 5 (b) 
also showed that the induction of JunB is mainly under the activation of 
MyD88-dependent pathway and can sustain longer time up to 12 h post 
PAMPs stimulations, suggesting that different mechanisms may regulate junb 
under MyD88 pathway and TRIF pathway.  
 
3.1.3 junb mRNA stability did not differ significantly under different 
PAMPs stimulation conditions  
We observed from Figure 1 and 2 that while the JunB protein level was 
expressed highly after 4 h post-stimulation, junb mRNA level dropped 
relatively quickly after the peak, except a prolonged lower peak of the junb 
mRNA between 10 h to 24 h in IR stimulation. This may be caused by 
post-transcriptional regulation, which can stabilize the mRNA. To verify this, 
we used actinomycin D treatment. Actinomycin D arrests RNA synthesis and 
transcription. Thus measurements are made on the life-span of pre-existing 
mRNAs produced under PAMP challenge. J774 cells were challenged with 
single (I or R) or combinatorial PAMP (IR) for 1 h, followed by actinomycin 
D treatment up to 2 h. Although junb mRNA under IR stimulation degraded 
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slightly faster than that in I and R stimulations, mRNA all died down by 2 h 
post actinomycin D treatment in all stimulations, indicating that the half-life 
variations are not significant under single or combinatorial PAMP stimulations 
(Figure 6 (a)). We conclude that the inconsistent expression levels between 
junb mRNA and JunB protein levels is not due to post-transcriptional 
regulation. 
 
3.1.4 JunB protein stability did not differ significantly under different 
PAMPs stimulation conditions  
Since the inconsistency in the expression levels between junb mRNA and 
JunB protein is not due to post-transcriptional regulation, it may be possible 
that the sustained level of JunB protein could be due to post-translational 
regulation, which can stabilize the JunB proteins. Here, we used 
cycloheximide (CHX) to investigate protein stability. CHX inhibits protein 
translation, thus blocking new protein synthesis. J774 cells were challenged 
with single (I or R) or combinatorial PAMP (IR) for 8 h, when the protein 
level was observed to be sustained highly while the mRNA was reduced 
(Figure 5). Cells were collected at 20, 40 min, 1, 1.5 and 2 h after 
cycloheximide treatment. The JunB protein in different PAMP stimulations all 
underwent degradation after 1 h post-cycloheximide treatment (Figure 6b), 
suggesting that the inconsistent levels of expression of junb mRNA and JunB 
protein is possibly due to post-translational regulation, and that some 
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uncharacterized proteins which needed to be produced constitutively might be 
involved in helping to sustain the level of JunB protein. 
The results from junb mRNA and JunB protein stability test suggest that 
some uncharacterized proteins which needed to be produced, might be 
constitutively involved in sustaining the JunB protein level, which is 
consistent with the result of previous study (Farras, Baldin et al., 2008). Other 
mechanisms such as the regulation by transcription factors may contribute in 
the differential transcription of junb mRNA. Another possible mechanism in 
controlling the stability of JunB protein is through the ubiquitin-proteasome 
pathway (UPP), which carries out the majority of intracellular protein 
degradation. UPP links chains of polypeptide co-factor, Ub, onto proteins to 
mark their degradation by three enzymic components E1 (Ub-activating 
enzyme), E2s (Ub-carrier or conjufating proteins) and E3 (Ub-protein ligase, 
which recognizes specific proteins and catalyzes the transfer of Ub to it) 
(Lecker et al., 2006). The maintenance of JunB protein might be due to the 
inhibition of the UPP, thus blocking the protein degradation pathway, enabling 
JunB accumulation.  
 




Figure 6. junb mRNA and JunB protein stability test. (a) Differences in the 
junb mRNA stability under single (I or R) and combinatorial PAMP (IR) 
stimulations. J774 cells were stimulated with either 10μg/ml poly(I:C) (I), 25 
ng/ml R848 (R) or combinatorial PAMP (IR) for 1 h, followed by adding 10 
μg/ml Actinomycin D. Cells were collected at 1 h and 2 h time points. junb 
mRNA level was quantified by real-time PCR, gapdh was used as internal 
control. (b) The JunB protein stability under single (I or R) and combinatorial 
PAMP (IR) stimulations. 80 μg/ml cycloheximide was added, after which cells 
were collected at 20, 40 min, 1, 1.5 and 2 h time points. JunB protein level 
was detected by Western blot. 
 
3.2 junb long promoter showed higher transcription activity 
Based on preliminary data, both junb mRNA and JunB protein appear to 
be induced by both single (I and R) and combinatorial (IR) PAMP stimulations, 
albeit to different degrees. The mechanisms underlying how and why JunB is 
induced remain unclear.  
(b) 
(a) 
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    Since a promoter is crucial for the regulation of gene transcription, we 
will begin by isolating and investigating the junb promoter. 
3.2.1 junb gene promoter region was characterized  
    To investigate the regulation of JunB under single (I and R) or 
combinatorial (IR) PAMP stimulations, junb promoter (-1527 bp to +536 bp) 
of 2063 bp was chosen for further investigation. This region contains TATA 
box, transcription start site, as well as the 5’ untranslated region (Figure 7(a)). 
3.2.2 junb promoter region was subcloned successfully 
    To simplify the study of junb promoter, we amplified the 2063 bp 
fragment from genomic DNA of J774 cells using PCR. This DNA region was 
ligased and cloned into pGEMT-easy vector. Subsequent DNA sequencing 
showed five bases to be different from the genome sequence found on NCBI 
database. Since this junb promoter sequence was analyzed using J774 cell line, 
we endeavoured to exclude the possibility that the differences in these five 
bases were caused by mutations of the J774 cells. We then used the genomic 
DNA extracted from mice primary bone marrow cells. The sequencing result 
showed the same five bases difference from the database sequence (Figure 
7(b)). Thus, the differences in these five bases from database are not due to 
mutations in J774 cell line, rather, the possible sequence errors entered into the 
database. Thus, our junb promoter sequence was submitted to Genebank 
(KF017545). 




Figure 7. Identification of junb gene promoter region. (a) Graphic 
identification of junb promoter region. Transcription start sites locates 37 
bases downstream the TATA box. (b) The five bases (red boxes) identified to 
be different blasting with NCBI database. Query is the DNA sequenced from 
J774 and mice bone marrow cells genomic DNA, Sbjct is the mouse genome 
sequence acquired from NCBI database. 
 
3.2.3 TF-binding sites within junb promoter were predicted in silico 
Transcription factors (TFs) play important roles in regulating gene 
expression through interacting with specific DNA sequence elements in the 
promoter and enhancer regions. Thus, bioinformatics analysis was conducted 
to predict the sequence elements on junb promoter to which TFs bind to. 
Softwares which were used include TFsearch, Alibaba2 and rVista. The whole 
2063 bp junb promoter was analyzed for potential TF binding sites (Figure 
8(a)) as well as the evolutionarily conserved regions (Figure 8(b)). 
According to the predicted TFs binding sites, several TFs that are 
possible in regulating the transcription activity of junb promoter were found, 
(b) 
(a) 
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such as NF-κB, AP-1, glucocorticoid receptor (GR), C/EBPβ. NF-κB is known 
to be involved in cellular responses to stimuli and plays a key role in 
regulating immune responses. AP-1 family, which includes JunB, regulates 
gene expression in response to a variety of stimuli such as cytokines, growth 
factors, stress, bacterial and viral infections. GR regulates genes controlling 
development, metabolism and immune response. C/EBPβ is crucial for normal 
macrophage functioning and it is also important in regulating genes involved 




Figure 8. Bioinformatic analysis of junb promoter. (a) Prediction of the TFs 
binding sites using Alibaba2, TFSEARCH and rVista. (b) The evolutionarily 
conserved regions prediction by ECR browser. ECR represents Evolutionarily 
Conserved Region. The mouse junb promoter -1527 to +536 shown in (a) was 
aligned with cow, chimp and human sequences. 
 
    Comparison of DNA sequences between different species is a useful 
method to help identify important fragments and elements. Mouse junb gene 
(a) 
(b) 
- 63 - 
 
was aligned with that of human, chimpanzee and cow. Compared with human 
junb promoter, besides the 5’ untranslated region (5’ UTR), five conserved 
regions have been predicted (Figure 5B). The 5’ UTR is 76% identical 
between mouse and human genes. The promoter regions just upstream of the 
transcription start sites are often conserved amongst species. In junb promoter, 
the evolutionarily conserved region 1 (ECR1) spans the transcription start site, 
with 80.7% identity between the mouse and human genes. The other four 
evolutionarily conserved regions, ECR2 to ECR5, reside just upstream of the 5’ 
UTR to 1.5 kb upstream, with a 70.0%, 69.8%, 77.5% and 73.0% identity 
between the two species, respectively (the junb promoter construct does not 
include the entire ECR5).  
 
3.2.4 Dual luciferase reporter assay showed that junb long promoter has 
high transcription activity  
To determine the functional regions and the important elements within 
the junb promoter in directing transcription activity, dual luciferase reporter 
assays were performed using mouse macrophage-like cell line, J774, to enable 
us to measure the transcription activities of different regions of the junb 
promoter under different PAMP stimulations. 
 Altogether, four 5’-deletion fragments of the junb promoter (1793bp, 
1328bp, 790bp and 324bp) were fused to the firefly luciferase reporter vector 
pGL4.2, as indicated in Figure 9(a). Dual luciferase reporter assays were 
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carried out by transfecting both the constructed firefly luciferase vectors and 
the control Renilla luciferase vectors into J774 cells for 24 h. The 
investigation of promoter activity shows that there were significant 
transcriptional activity within the -1527 bp to -1063 bp and -524 bp to -59 bp  
regions of the junb promoter (Figure 9(b)). Aligning to the previous 
bioinformatics analysis, several transcription factors that are possible in 
regulating the transcription activity of junb promoter within these two 
important regions were found, namely, NF-κB, AP-1, GR, C/EBPβ.  
Next, we investigated whether PAMP stimulation will enhance the 
exogenous junb promoter activity and whether different promoter regions have 
different transcription activities in the dual luciferase reporter assay. J774 cells 
were transfected with different constructs of the firefly luciferase vectors for 
24 h, followed by single (I or R) or combinatorial PAMP (IR) stimulation for 
2h, allowing the highest junb transcription activity according to previous result 
(Figure 5). Compared with the non-treated cells (Figure 9(b)), the relative 
promoter activity of junb promoter was not enhanced in the PAMP stimulated 
cells, and the promoter activity was not significantly different between 
different PAMP stimulations (Figure 9(c)). This is inconsistent with our 
observation that IR induces the highest junb mRNA in J774 cells (Figure 5). 
One possible explanation for this is that the promoter region alone is not 
sufficient for the different transcription of junb under different PAMPs 
stimulations. 






Figure 9. The dual luciferase reporter assay to examine junb promoter activity. 
J774 cells were transfected by X-tremeGENE with constructed firefly 
luciferase reporter vectors and the control Renilla luciferase vectors. Relative 
promoter activity was calculated as the corrected activity of firefly luciferase 
by Renilla luciferase. (a) The schematic representative of the luciferase 
reporter gene constructs using pGL4.2 vector. Four different length of junb 
promoter was cloned into pGL4.2 vector, followed by a luciferase gene. (b) 
The relative promoter activity of the junb promoter with 1793 bp, 1328 bp, 
790 bp and 324 bp flanking the junb promoter region. (c) The relative 
promoter activity of the four different flanking regions of junb promoter under 
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3.3 The identification of TFs regulating junb through the interaction 
between junb promoter and nuclear extract proteins was unsuccessful  
     Both the junb mRNA and JunB protein are induced under I, R and IR 
stimulations, with relatively milder induction under I stimulation, stronger 
under R and further enhanced under IR. This observation posed an interesting 
question about what transcription factors contribute to regulation of the 
expression of JunB under different PAMP stimulations. In order to clarify 
which region of the junb promoter and which TFs are important in regulating 
the transcription activity of junb promoter under different PAMP stimulations 
by far, EMSA and pulldown assay were carried out. 
 
3.3.1 junb promoter probes were able to bind with nuclear extract 
proteins from different PAMP stimulations  
Firstly, we generated three junb promoter DNA biotin-labeled probes of 
different lengths (2063 bp, 1060 bp and 594 bp) (Figure 10(a)), according to 
previous bioinformatics analysis. Nuclear extract proteins were collected from 
J774 cells treated with I or R or IR, and the quality and presence of JunB and 
IRF1 proteins were verified by using Western blot (Figure 10(b)). IRF1 
protein was chosen because the recent study from our lab showed that IRF1 
was mainly responsive for TRIF-dependent pathway, suggesting that IRF1 was 
induced mainly under I treatment(Liu, Zhu et al., 2015). The Western Blot 
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result showed that the nuclear extract had reached the required quality, with 
JunB induced mildly in I, stronger in R and further enhanced in IR stimulation, 
and IRF1 was mainly induced in I and IR stimulations. 
To confirm whether the generated biotin-labeled DNA probes were 
functional, EMSA experiments were carried out. The biotin-labeled DNA 
probes were incubated with nuclear extract and electrophoresed on agarose gel. 
The biotin signals were detected by using streptavidin antibody. A shift in all 
three probes after incubating with nuclear extract proteins can be observed 
(Figure 10(c)), indicating that the biotin-labeled probes worked properly. 
However, we are not able to observe the differences in band shift within the 
same DNA probe incubated with different nuclear extract protein samples 
from NT, I, R and IR. This might be because the DNA probes are relatively 
long so that many transcription factors (specific or nonspecific) were bound to 










Figure 10. The binding pattern of nuclear extract from NT, I, R and IR  
stimulations with three different regions of junb promoter. (a) The schematic 
presentative of the biotin-labeled DNA probes. Biotin was added to both ends 
of DNA fragments, represented by orange circles. (b) J774 cells were 
stimulated with either 10μg/ml poly(I:C) (I), 25ng/ml R848 (R) or 
combinatorial PAMP (IR) for 4 h. Nucleus were isolated and proteins were 
extracted using high salt solution as described before. The protein samples 
were separated by SDS-PAGE gel, transferred to PVDF membrane and blotted 
with JunB antibody and IRF1 antibody. (c) EMSA experiments by incubating 
biotin-labeled junb promoter DNA probes with nuclear extract. The DNA 
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3.3.2 The DNA-protein pulldown assay and silver staining protein bands 
showed no difference between different PAMPs stimulations  
 Since we were not able to observe differential band shifts under I, R and 
IR stimulations in EMSA experiment, in order to obtain a clear picture about 
the differences in the binding pattern of TFs under different PAMP 
stimulations, pulldown assay was conducted as well as silver staining. 
The same DNA probes were incubated with nuclear extracts from I or R 
or IR stimulations, as described in previous EMSA experiments. The pulled 
down protein samples were electrophores followed by silver staining. We 
expected to see differences from the profile of pulled down proteins by 
different probes as well as from the pulled down samples under different 
stimulations using the same probe. However, we were not able to observe a 
clear difference from silver staining (Figure 11), this might partly be due to 
the large amounts of proteins being pulled down by relatively long DNA 
fragments. Another possibility may be that the nuclear extract used in the 
pulldown assay was prepared 4 h after PAMP stimulations, in which the 
variation of the amount and types of TFs which are important in regulating 
junb transcription under different PAMP stimulations is less significant or their 
differences have become compromised over the 4-hour period.  
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Figure 11. Pull down assay using different length biotin-labeled junb promoter 
probes and nuclear extract proteins. Pulled down (PD) samples were run on 
SDS-PAGE gel, followed by silver staining. 
3.4 junb promoter and enhancer cooperated to enhance the transcription 
of junb 
    Previous experiments showed that promoter activity was not significantly 
different between different PAMP stimulations in dual luciferase assay, so we 
further considered a junb downstream region. 
3.4.1 A cluster of TF binding sites was predicted in the junb enhancer 
    The downstream 967 bp region (+1349 bp to +2316 bp) of junb contains 
a 3’UTR, a polyadenylation signal and an enhancer region (Figure 12(a)). 
Again, bioinformatics analysis was conducted to predict the potentially 
functional sequence elements on junb downstream region to which TFs bind to. 
Softwares used include TFsearch, Alibaba2 and rVista were used. The junb 
downstream region was analyzed for potential TF binding sites (Figure 
12(b)). 






Figure 12. Identification of junb gene downstream region. (a) The graphic 
identification of junb downstream region. Downstream of junb contains polyA 
tails and an enhancer region of around 200 bp. (b) Bioinformatic analysis of 
junb downstream region using Alibaba2, TFSEARCH and rVista. 
 
    From the bioinformatic analysis result, a cluster of transcription factors 
were predicted binding to the junb downstream enhancer region, indicating an 
important role of the enhancer in regulating junb transcription. These 
transcription factors include NF-κB, AP-1, GR, C/EBPβ, as well as KBP-1, 
RelA, c-Rel. 
 
3.4.2 The junb promoter and enhancer were subcloned successfully 
To determine the functional elements within the junb promoter and 
downstream 3’UTR regions, which might be involved in directing 
(a) 
(b) 
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transcription activity, we fused junb promoter and downstream 3’UTR into a 
firefly luciferase reporter vector pGL3-Basic. Two 5’ deletion fragments of the 
junb promoter (referred to as long promoter of 1793 bp and short promoter of 
657 bp) were fused upstream of the firefly gene, and the downstream 3’UTR 
of 967 bp was fused downstream of the firefly luciferase gene (Figure 13). 
 
 
Figure 13. The schematic representative of the luciferase reporter gene 
constructs using pGL3-Basic vector. Two different length of junb promoter 
and/or a junb downstream region were cloned into pGL3-Basic vector, 
flanking a luciferase gene. 
 
3.4.3 The 3’UTR enhancer strongly upregulates the junb transcription 
together with promoter  
To investigate whether single (I or R) and combinatorial PAMP (IR) 
stimulations will enhance the junb promoter activity and whether different 
promoter and/or 3’UTR have different transcription activities, dual luciferase 
reporter assays were carried out by transfecting both the constructed firefly 
luciferase vectors and the control Renilla luciferase vectors into J774 cells for 
24 h, followed by single (I or R) or combinatorial (IR) stimulation for 2 h. 
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This condition was previously shown to allow the highest junb transcription 
activity (Figure 5). The 3’UTR region showed significant transcriptional 
activity (Figure 14), suggesting its importance in regulating junb 
transcription. 
 
Figure 14. The dual luciferase reporter assay to examine junb promoter and 
downstream enhancer activity. J774 cells were transfected by X-tremeGENE 
with constructed firefly luciferase reporter vectors and the control Renilla 
luciferase vectors. Relative promoter activity was calculated as the corrected 
activity of firefly luciferase by Renilla luciferase. The relative activity of the 
five different flanking regions of junb promoter and/or downstream enhancer 
under single PAMP (I or R) and combinatorial PAMPs (IR) stimulations. 
 
3.4.4 Four NF-κB binding sites in junb enhancer region up-regulated the 
transcription of junb  
    A study of junb in mouse dendritic cells have shown that the binding of 
NF-κB to the enhancer under LPS stimulation is important in regulating junb 
(Salem, Gomard et al., 2013). Four NF-κB sites have been predicted in the 
mouse macrophage cell line, J774, as described before (Figure 12(b)). Thus, it 
was pertinent to investigate whether these NF-κB sites contribute towards 
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regulating junb in macrophages.  
Five mutation combinations were chosen. Mutant 1 represents the 
mutations in all four NF-κB sites. Mutant 2 has the triple mutations in second, 
third and fourth NF-κB sites. Mutant 3, 4 and 5 are single mutants, which has 
mutation in second, third and fourth NF-κB site, respectively. Figure 15(a) 
shows a diagrammatic illustration of the mutant constructs indicating the 
respective NF-B sites in each of the mutants. 
Dual luciferase reporter assays were carried out by transfecting both the 
constructed firefly luciferase vectors and the control Renilla luciferase vectors 
into J774 cells for 24 h, followed by single I or R or IR stimulation for 2 h. 
Results shown in Figure 15 show that the presence of junb enhancer region 
greatly up-regulated the transcription significantly. And when the four NF-κB 









Figure 15. The dual luciferase reporter assay to examine the activity of junb 
promoter and downstream enhancer with NF-κB mutations. J774 cells were 
transfected by X-tremeGENE with constructed firefly luciferase reporter 
vectors with different NF-κB mutations and the control Renilla luciferase 
vectors. Relative promoter activity was calculated as the corrected activity of 
firefly luciferase by Renilla luciferase. The relative activity of the five 
different flanking regions of junb promoter and/or downstream enhancer under 
single PAMP (I or R) and combinatorial PAMPs (IR) stimulations. (a) The 
schematic representative of the NF-κB mutation combinations. (b) The 
relative promoter activity of the junb short promoter with different NF-κB 
sites mutations. (c) The relative promoter activity of the junb long promoter 
with different NF-κB sites mutations under single PAMP (I or R) and 
combinatorial PAMPs (IR) stimulations. The data is based on 3 independent 
experiments, statistical significance was calculated using two-tailed Student's 
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With the presence of both junb short promoter and 3'UTR, Mutant 2 
abolished transcription but to a smaller extent compared with Mutant 1, 
suggesting that the first NF-κB binding site plays a part in regulating the 
transcription. In Mutant 3, when the second NF-κB site was mutated, the 
transcription activity was not abolished compared to the original 3'UTR, 
suggesting that the second NF-κB site may not be essential in regulating junb 
together with junb short promoter. Mutant 4 and 5 each showed a certain 
reduction in junb transcription, with a larger reduction in the third NF-κB 
mutation, indicating that the third NF-κB site plays a greater role in regulating 
transcription than the fourth NF-κB site.  
When junb 3'UTR coexisted with junb long promoter, Mutant 2 with the 
mutation in the last three NF-κB sites also abolished junb transcription in all 
PAMPs treatments conditions significantly except in I stimulation alone. 
Individual mutation of the last three NF-κB sites all showed a certain 
reduction in junb transcription. However, the degree of transcription 
abolishment differs in different PAMP stimulation conditions. In NT and R 
stimulation, Mutant 5 showed the highest impact in transcription activity, 
followed by Mutant 4 and Mutant 3. In I stimulation, the transcription activity 
was abolished the most in Mutant 5 and Mutant 3, but Mutant 4 with the single 
mutation in the third NF-κB site had a less impact. In IR combinatorial 
stimulation, the individual mutations showed similar impact on transcription 
activity. These results suggested that with the presence of junb long promoter, 
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the regulation of junb transcription is more complicated under different 
PAMPs stimulations, suggesting that there may be important regulatory 
elements within the long promoter region that act directly with 3'UTR 
enhancer or act indirectly through short promoter to influence 3'UTR, thus 
regulating junb transcription. 
These results all showed that these four NF-κB binding sites may 
cooperate together to regulate junb in the most appropriate manner under 
different PAMP stimulation conditions. 
 
3.5 Transfecting plasmid DNA into J774 cells affected the expression of 
JunB protein  
From previous results, we were not able to see significant differences 
between various constructs under I, R and IR stimulations in the dual 
luciferase assay, we hypothesize that the transfection procedure may influence 
J774 cells. So we investigated the effect of transfection procedure using 
X-tremeGENE HP DNA Transfection Reagent on J774 cells. 
 
3.5.1 X-tremeGENE HP DNA Transfection Reagent did not affect JunB 
expression in J774 cells  
To investigate whether the transfection procedure affects the expression 
of JunB in J774 cells, we first tested the impact of the X-tremeGENE HP DNA 
Transfection Reagent alone to J774 cells. J774 cells were transfected with or 
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without X-tremeGENE for 24 h, followed by I or R or IR stimulation for 5 h. 
Cells were lysed and JunB was detected using Western blot. The expression of 
JunB was not affected by X-tremeGENE under I or R or IR stimulation 
(Figure 16(a)). Result showed that the X-tremeGENE HP DNA Transfection 
Reagent alone does not affect the expression of JunB in J774 cells. 
 
3.5.2 Transfection of plasmid DNA into J774 cells led to abnormal 
expression of JunB protein  
Next, we investigated whether transfection of plasmid DNA will affect 
J774 cells. J774 cells were transfected with junb downstream 3’UTR or long 
promoter or long promoter+downstream 3’UTR luciferase construct for 24 h, 
followed by I or R or IR stimulation for 5 h. Cells were lysed and JunB was 
detected using Western blot. Cells transfected with plasmid showed higher 
expression level of JunB under no PAMP stimulation. On the other hand, cells 
transfected with plasmid had lower expression level of JunB under PAMP 
stimulations, either I or R or IR stimulation, compared to cells without plasmid 
transfection (Figure 16(b)). To further investigate whether the impact on JunB 
expression is due to the artificially insertion of junb promoter and downstream 
fragments, pGL3-Basic vector was used as a positive control. J774 cells 
transfected with pGL3-Basic vector or long promoter+downstream 3’UTR 
luciferase construct showed lower expression of JunB under PAMPs 
stimulations (Figure 16(c)). This suggests that the transfection of plasmid 
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DNA into J774 cells will affect the expression of JunB, which explains why no 
significant difference was observed in previous dual luciferase assay, with the 





Figure 16. Western blot for JunB expression under plasmid DNA transfection 
condition. (a) Whole cell lysis from J774 with or without X-tremeGENE 
transfection under single (I or R) or combinatorial PAMP (IR) stimulations 
were resolved on SDS-PAGE gel, transferred to PVDF membrane and probed 
with antibodies against JunB and GAPDH (internal control). (b) Whole cell 
lysis from J774 with or without plasmid DNA transfection under different 
PAMP stimulations were resolved on SDS-PAGE gel, transferred to PVDF 
membrane and probed with antibodies against JunB and GAPDH (internal 
control). (c) Whole cell lysis from J774 with 400 ng, 800 ng, 1200 ng 
pGL3-Basic vector transfection under different PAMP stimulations were 
resolved on SDS-PAGE gel, transferred to PVDF membrane and probed with 
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3.6 junb promoter and 3'UTR interact to regulating junb  
    From the transfection and dual luciferase assay, we were unable to 
delineate the functional regions that regulate junb under different PAMP 
stimulations, so we proceeded to analyzing the junb promoter and enhancer by 
co-pulldown assay, with the aim to identify transcription factors that may 
contribute in regulating junb activity. 
 
3.6.1 junb promoter and 3’UTR showed a co-shift pattern with nuclear 
extract proteins 
junb promoter together with the 3’UTR region are important in regulating 
the transcription activity of junb, and the expression of both junb mRNA and 
JunB protein are induced under I, R and IR stimulations, with relatively milder 
induction under I stimulation alone, stronger under R alone and further 
enhancement under co-stimulation by IR. It was therefore imperative to 
examine whether junb promoter and enhancer region interact and coorperate in 
junb transcription. However, we were not able to clearly delineate the 
functional regions within junb promoter and enhancer under single (I or R) 
and combinatorial (IR) stimulations, as described in Section 3.5. So we 
proceeded to perform pull-down assay with the aim of finding some TFs 
which may be involved in regulating junb. Towards this goal, we labelled the 
long junb promoters (1793 bp) and the 3’UTR (967 bp) with biotin and used 
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them as probes (Figure 17(a)). Nuclear extract proteins were purified from 
J774 cells treated with I or R or IR for 1.5 h, during which the transcription 
activity of junb reached the peak. The quality of the nuclear extract was 
indicated by JunB protein verified using Western blot (Figure 17(b)). JunB 
protein was induced in either I or R or IR stimulations (Figure 17(b)), which is 
consistent with the previous time course experiment (Figure 5).The Western 
blot result shows that nuclear extract was of the required quality for use in 
further investigations of the junb promoter and enhancer activities. 
     To confirm whether the biotin-labeled DNA probes were functional, 
EMSA experiments were carried out. Biotin-labeled DNA probes were 
incubated with the purified nuclear extract and resolved on agarose gel. The 
biotin signals were detected by streptavidin antibody. A shift was observed in 
these DNA probes after incubating with nuclear extract proteins (Figure 
17(c)), thus verifying the integrity of the probes.  
    Next, the possibility of interaction between junb promoter and 
downstream enhancer regions was investigated using co-shift EMSA 
experiment. junb promoter and downstream DNA probes were co-incubated 
with nuclear extract from I or R or IR stimulated J774 cell nuclear extracts. 
After separation on the agarose gel, the biotin signals detected by streptavidin 
antibody showed a co-shift pattern (Figure 17(d)). 
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Figure 17. Binding pattern of nuclear extract under different PAMP 
stimulations with different junb promoter and downstream 3’UTR probes. (a) 
The schematic representative of the biotin-labeled DNA probes, represented 
by purple lines. (b) J774 cells were stimulated with either single (I or R) or 
combinatorial PAMPs (IR) for 1.5 h. Nucleus were isolated and proteins were 
extracted using nuclear extract buffer. The protein samples were separated by 
SDS-PAGE gel, transferred to PVDF membrane and blotted with JunB, TBP 
and GAPDH antibodies. (c) EMSA experiments by incubating biotin-labeled 
junb promoter and downstream DNA probes with nuclear extract. The DNA 
probes without nuclear extract were used as negative controls. (d) Co-shift 
experiment by incubating both junb promoter and downstream DNA probes 
with nuclear extract. 
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3.6.2 The conditions for co-pulldown assay and silver blue staining were 
optimized for mass spectrometry analysis 
 To identify the different kinds of transcription factors linking the junb 
promoter and downstream 3'UTR regions and regulating junb transcription, 
co-pulldown assay by using both junb promoter and 3'UTR DNA fragments 
was conducted followed by silver blue staining. 
The biotin-labeled DNA probes used in the co-shift experiment (long 
promoter and 3'UTR) were incubated with nuclear extracts purified from I or 
R or IR stimulations for 1.5 h, as described in previous co-shift experiment. 
The pulled down protein samples were run on electrophoresis gel followed by 
silver blue staining. The purpose of this experiment was to optimize the 
condition of co-pulldown in order to scale up the co-pulldown to enable the 
isolation of sufficient proteins for mass spectrometric analysis. We expected to 
see different protein band profiles from the pulled down samples under 
different stimulations. In Figure 18(a), protein bands can be observed in the 
silver blue staining gel. Thus, the condition for co-pulldown was optimized for 
the subsequent mass spectrometric analysis. We scaled up the co-pulldown 
reaction volume by six times, after confirming the co-pulldown samples by 
resolving on 3 layers SDS-PAGE (Figure 18 (b)). The co-pulldown proteins 
were then extracted from the PAGE gel and analysed by mass spectrometry.  
 
 




Figure 18. Co-pulldown assay using biotin-labeled junb promoter and 3'UTR 
probes with nuclear extract proteins. Protein samples were run on SDS-PAGE 
gel, followed by silver blue staining. (a) Small scale co-pulldown to optimize 




3.7 Potential junb regulatory TFs: AATF, SSRP1 and TARDBP were 
selected from mass spectrometry analysis  
    junb promoter and 3’UTR enhancer DNAs probes used in previous 
co-pulldown assay in Section 3.6.1 were used in co-pulldown experiments. 
DNA probes were incubated with nuclear extract of J774 cells stimulated with 
NT, I, R, IR. Co-pulldown samples were sent for mass spectrometry at the 
NUS PPC Center. Data was analyzed using ProteinPilot 4.0 software. Protein 
with an unused score of over 1.3 was chosen, since the unused score reflects 
the amount of total and unique peptide evidence related to a given protein. An 
unused score of 1.3 represents 95% of confidence (Ghosh et al., 2013). 
    From all the proteins identified from NT, I, R and IR, altogether 47 
transcription factors were found (Table 6). PANTHER (protein annotation 
through evolutionary relationship), a software that combines gene ontology, 
function, pathways and statistical analysis was used to analyse the pulled 
(a) (b) 
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down proteins. Proteins highlighted in red are the potential transcription 
factors that may be involved in regulating transcription. Most of the 
transcription factors identified are present in all the co-pulldowns, indicating 
that transcription factors required by junb transcription are pre-existing. Other 
mechanisms such as chromatin remodeling may regulate junb transcription. 
    In order to determine whether these transcription factors identified are 
induced or modulated by PAMP stimulations, a semi-quantitative evaluation of 
the protein amount using emPAI (exponentially modified protein abundance 
index) score was carried out. The emPAI score was calculated by Mascot 
analysis using SwissProt database. Proteins present in all conditions (NT, I, R 
and IR) were selected. We compared the emPAI fold-change between I and NT, 
R and NT, IR and NT in a same protein. Proteins with a fold-change of over 
1.5 (considered up-regulated) and below 0.5 (considered down-regulated) are 
highlighted in red (Table 7).  
    By analyzing the emPAI score, we found three nucleic acid-binding 
transcription factors: AATF, SSRP1 and TARDBP, to be up-regulated upon 
PAMP stimulations. AATF may function as a general inhibitor of the histone 
deacetylase, HDAC1. SSRP1 is involved in chromatin remodeling, suggesting 
again that the regulation of junb may be partly due to the modulation of 
chromatin, which may also explain why junb is a primary fast-responding 
gene. TARDBP is a DNA- and RNA- binding protein, which regulates 
transcription and splicing, it may also be involved in microRNA biogenesis, 
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apoptosis and cell division.  
    To validate the binding of these TFs with junb promoter and 
enhancer regions, western blot was carried out using the co-pulldown protein 
samples (Figure 19). The result showed that TARDBP was detected in the 
co-pulldown samples using Western blot. But the protein bands were of the 
same intensity, indicating that these may be nonspecific bands. We are not able 
to conclude the different binding of TARDBP to junb promoter and enhancer 
under different PAMPs stimulations. The low concentration of AATF and 
SSRP1 proteins in the co-pulldown samples may be the reason why they were 
undetected by Western blot and that the antibody was not working properly, 
antibodies from other sources are needed to be tested in future study. Also, if 
the chromatin remodeling indeed contributes in regulating junb, the initiation 
of chromatin remodeling will occur ahead of the peak of junb transcription. 
The nuclear extract proteins used in this junb co-pulldown assay was extracted 
1.5 h post PAMPs stimulations, when the junb mRNA was most highly 
transcribed (Figure 5), the initial of chromatin remodeling may be earlier than 
this time point, giving us a possible reason for not able to detect the binding of 
TFs in this Western Blot analysis. It will be necessary to perform co-pull down 
assay using nuclear extract from earlier time points such as within 30 min post 
stimulations. In the future, the binding of TARDBP, AATF and SSRP1 
proteins with DNA and whether TARDBP has a functional role in regulating 
junb will need further varification. Also, chromatin remodeling will be another 
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interesting aspect for studying the regulatory mechanism of junb. 
    Furthermore, the sustained level of JunB (Figure 5) may be regulated via 
UPP. Upon PAMPs stimulations, especially R848 stimulation, UPP might be 
blocked by yet to be identified protein components. We sought to find out the 
differential expression levels of 26S proteasome components such as E1, E2s 
and E3 or other UPP-related proteins from our co-pull down mass 
spectrometry results. We did find several UPP related proteins such as E3, 
Fbxo11 (F-box only protein 11), Cbll1 (E3-ubiquitin-protein ligase Hakai), 
Uhrf1 (E3 ubiquitin-protein ligase UHRF1) in our mass spectrometry result of 
the co-pull down protein samples, but their emPAI fold changes did not have 
significant differences between R stimulation and NT, I stimulations. And the 
results derived from co-pull down assay is not that convincing since the UPP 
related proteins carry out their functions in cytoplasm and need not bind to the 
junb promoter and enhancer. Thus using mass spectrometry analysis to 
compare the protein profiles of whole cell proteins under different PAMPs 
stimulations will be necessary to investigate whether UPP related proteins 
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Figure 19. Western blot validation of TFs binding with DNA. J774 cells were 
stimulated with either 10μg/ml poly(I:C) (I), 25ng/ml R848 (R) or 
combinatorial PAMP (IR) for 1.5 h. Nucleus were isolated and proteins were 
extracted using high salt solution as described before. The protein samples 
were incubated with junb promoter and enhancer biotin labeled probes, 
co-pulldowned and crosslinked before separated by SDS-PAGE gel, 




Table 6. Transcription factors identified by mass spectrometry analysis 
Name Symbol NT I R IR 
Histone acetyltransferase KAT7 Kat7 √ √ √ √ 
Leucine-rich repeat flightless-interacting 
protein 2 
Lrrfip2 √ √ √ √ 
Transcription factor PU.1 Spi1 √ √ √ √ 
FACT complex subunit SSRP1 Ssrp1 √ √ √ √ 
PC4 and SFRS1-interacting protein Psip1 √ √ √ √ 
Protein AATF Aatf √ √ √ √ 
MYB-Binding protein 1A Mybbp1a √ √ √ √ 
Thyroid hormone receptor-associated 
protein 3 
Thrap3 √ √ √ √ 
RNA-binding protein 14 Rbm14 √ √ √ √ 
Zinc finger protein 512 Znf512 √ √ √ √ 
Staphylococcal nuclease 
domain-containing protein 1 
Snd1 √ √ √ √ 
Methionine aminopeptidase 1 Metap1 √ √ √ √ 
TAR DNA-binding protein 43 Tardbp √ √ √ √ 
Bcl-2-associated transcription factor 1 Bclaf1 √ √ √ √ 
Polyhomeotic-like protein 2 Phc2 √ √ √ √ 
THO complex subunit 2 Thoc2 √ √ √ √ 
Hypermethylated in cancer 2 protein Hic2 √ √ √ √ 
Transcription elongation factor B Tceb3 √ √ √ √ 
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polypeptide 3 
Zinc finger protein 281 Znf281 √ √ √ √ 
Enhancer of rudimentary homolog Erh √ √ √ √ 
Methyltransferase-like protein 14 Mettl14 √ √ √ √ 
RNA-binding protein FUS Fus √ √ √ √ 
Polyadenylate-binding protein 1 Pabpc1 √ √ √ √ 
Zinc finger protein 740 Znf740 √ √ √ √ 
Hematopoietic lineage cell-specific protein Hcls1 √ √ √ √ 
CCAAT/enhancer-binding protein zeta Cebpz √ √ √ √ 
Heterogeneous nuclear ribonucleoprotein 
Q 
Syncrip √ √ √ √ 
LIM domain and actin-binding protein 1 Lima1 √ √ √ √ 
Sp110 nuclear body protein Sp110 √ √ √ √ 
ELAV-like protein 1 Elavl1 √ √ √ √ 
KH domain-containing, RNA-binding, 
signal transduction-associated protein 1 
Khdrbs1 √ √ √ √ 
Zinc finger protein 710 Znf710 √ √   
Cell division cycle 5-like protein Cdc5l √   √ 
Zinc finger and SCAN domain-containing 
protein 26 
Zscan26 √   √ 
DNA-directed RNA polymerase I subunit 
RPA43 
Twistnb √ √  √ 
Atherin Samd1  √ √  
Mortality factor 4-like protein 1 Morf4l1  √ √ √ 
Proliferation-associated protein 2G4 Pa2g4  √ √ √ 
Mortality factor 4-like protein 2 Morf4l2   √  
High mobility group protein B2 Hmgb2   √  
Transcription termination factor 1 Ttf1   √  
Recombining binding protein suppressor 
of hairless 
Rbpj   √  
Transcriptional activator protein Pur-alpha Pura   √  
Smad nuclear-interacting protein 1 Snip1    √ 
General transcription factor IIH subunit 4 Gtf2h4    √ 
Zinc finger X-chromosomal protein Zfx    √ 
Zinc finger and BTB domain-containing 
protein 7A 
Zbtb7a    √ 
Proteins highlighted in red are the potential transcription factors that may be 
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Table 7. emPAI score fold change of transcription factors identified from mass 
spectrometry 
Name Symbol I/NT R/NT IR/NT 
Histone acetyltransferase KAT7 Kat7 1 0.83871 1.193548 
THO complex subunit 2 Thoc2 0.955224 1.089552 1 
FACT complex subunit SSRP1 Ssrp1 1 1.122449 1.530612 
MYB-Binding protein 1A Mybbp1a 1.206331 1.235639 1.048066 
Polyhomeotic-like protein 2 Phc2 1 1 1 
Protein AATF Aatf 1.291667 1.583333 1.291667 
Bcl-2-associated transcription 
factor 1 
Bclaf1 1.113636 1.431818 1.113636 
Transcription factor PU.1 Spi1 nil nil nil 
TAR DNA-binding protein 43 Tardbp 1.791667 1.375 1.375 
Leucine-rich repeat 
flightless-interacting protein 2 
Lrrfip2 1 0.466667 
 
1 
PC4 and SFRS1-interacting 
protein 
Psip1 nil nil nil 
Zinc finger protein 512 Znf512 0.891566 1.108434 0.891566 
Zinc finger protein 281 Znf281 1 1 1 
Zinc finger protein 740 Znf740 1 1 1 
CCAAT/enhancer-binding 
protein zeta 
Cebpz 1 0.891089 0.891089 
Staphylococcal nuclease 







Hypermethylated in cancer 2 
protein 
Hic2 nil nil nil 











Grp1: Chromatin modeling; 
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Chapter 4: Discussion 
    Innate immunity has been receiving fast-growing attention since the 
discovery of PRRs and PAMPs. Hosts protect themselves from pathogens by 
using PRRs to recognize the pathogen PAMPs. Extensive research is ongoing 
to elucidate the roles of PRRs, their target PAMPs as well as the downstream 
effectors they recruit (Takeuchi and Akira, 2010; Netea and van der Meer, 
2011). However, in reality a pathogen carries more than one 
pathogen-associated molecular pattern (PAMP), the host would 
simultaneously encounter several types of PAMPs during. To eliminate 
pathogens most efficiently, PRRs may crosstalk to regulate the appropriate 
immune responses (Agrawal, Agrawal et al., 2003; Brown, Herre et al., 2003; 
Gantner, Simmons et al., 2003; Dennehy, Ferwerda et al., 2008; Netea, Brown 
et al., 2008). Thus it is significant to investigate the crosstalk between PRRs 
and the molecular mechanisms which may explain such crosstalks. Within 
PRRs, the TLR family is the most well-studied. Previous research showed that 
the combinatorial stimulations of TLR3, which recognize viral 
double-stranded (ds) RNA, and TLR7, which sense viral single-stranded (ss) 
RNA, pathways lead to the strongest cytokine synergy effect (Suet Ting Tan et 
al., 2013), however the mechanisms underlying the crosstalk remains unclear.  
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4.1 JunB was induced under PAMP stimulations in macrophages 
    JunB was shown to be induced under LPS stimulation in mouse dendritic 
cells, mouse macrophages cell lines, J774 and RAW264.7 (Frazier-Jessen, 
Thompson et al.; Fujihara, Muroi et al., 1993). These studies focused on LPS, 
which particularly activates TLR4. TLR4 triggers both Myd88- and TRIF- 
signaling pathways. However, information is lacking on whether junb is also 
responsible under single (I-polyI:C, activating TLR3; and R-R848, activating 
TLR7) and double (IR) stimulations in mouse macrophages. Here, we showed 
that both junb mRNA and JunB protein were induced under I, R and IR 
stimulations (Figure 5). junb behaved as an immediate early gene in 
macrophages since it is induced rapidly after stimulations, which makes sense 
since macrophages function primarily in innate immunity as a first line 
protector. This induction pattern of JunB in macrophages is similar to that in 
mouse dendritic cells (Salem, Gomard et al., 2013). Upon stimulations, the 
level of JunB protein was sustained compared to the relatively rapid drop of 
junb mRNA (Figure 6), which was the same as in BMDC (Gomard, Michaud 
et al., 2010), suggesting that there might be some uncharacterized proteins 
which needed to be produced to help sustain the JunB protein level. This 
reasoning is consistent with the results of previous study (Farras, Baldin et al., 
2008; Salem, Gomard et al., 2013). The differential expression of JunB protein 
also suggests that different mechanisms may regulate junb in MyD88 pathway 
and TRIF pathway. Transcriptional regulation may contribute in junb 
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regulation under TRIF pathway and post-translational regulation in MyD88 
pathway. The second possibility of JunB maintenance is due to the regulation 
of UPP related proteins such as ubiquitination subjecting JunB towards 
degradation. JunB protein is mainly induced and sustained by R848 
stimulation, suggesting that JunB expression may mainly induced by MyD88 
dependent pathway. The analysis of the expression profile of UPP-related 
proteins in whole cell lysis under different PAMPs stimulations will be needed 
to investigate the role of UPP in regulating JunB protein stability.  
    Another possible pathway that may regulate JunB protein stability is the 
c-Jun NH2-terminal kinase (JNK) pathway (Fuchs et al., 1997). Previous study 
about c-Jun stability showed that by association with JNK, c-Jun is targeted 
for ubiquitination, and the phosphorylation of c-Jun by JNK protects c-Jun 
from ubiquitination, prolonging c-Jun life span (Fuchs et al., 1996). Studies 
also showed that JNK targets JunB ubiquitination in mouse fibroblasts (Fuchs, 
Xie et al., 1997), and JunB protein is extensively phosphorylated upon 
induction (Liu, Zhu et al., 2015), and sustains at high level for relative long 
time (Figure 5). We thus wondered whether the phosphorylation of JunB 
protects it from ubiquitination via JNK pathway, prolonging its life-span. It is 
therefore, interesting to investigate the mechanisms in stabilizing JunB protein 
under PAMP stimulations in macrophages in the future. 
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4.2 The 3'UTR enhancer upregulates junb transcription 
    junb promoter has been studied in other cell types, such as a Smad 
binding element (SBE) in P19EC embryonal carcinoma cells (Jonk, Itoh et al., 
1998) and an Ets-binding site as well as a CRE-like site in hepatoma cell line 
HepG2 (Nakajima, Kusafuka et al., 1993). Furthermore, one NF-κB sites 
downstream of the junb gene was identified to be responsible for IL-6 
stimulation (Brown, Ades et al., 1995). We have shown here that with the 
presence of junb 3'UTR including the enhancer region, the transcription 
activity of junb was largely enhanced, suggesting an important role of junb 
downstream region (Figure 14). However, we were not able to clarify which 
part of the junb promoter or/and downstream region(s) play a central role in 
regulating junb transcription when using the dual luciferase assay. One 
possible reason is that the transfection of plasmid DNA into J774 cells using 
X-tremeGENE HP DNA Transfection Reagent affected J774 cells, thus 
influencing the expression of endogenous JunB (Figure 15), which has also 
been reported previously (Van De Parre et al., 2005). Whether other 
transfection methods such as nucleofection would affect JunB expression in 
J774 cells still remains an open issue. 
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4.3 The cooperation of junb promoter and downstream 3'UTR  
    It has been reported before that the junb downstream enhancer region was 
essential in cooperating with junb promoter by forming a stable chromatin 
loop and bringing them into close spatial proximity, to regulate junb 
transcription rapidly under LPS stimulation in BMDC (Salem, Gomard et al., 
2013). In this thesis work, we have shown that in mouse macrophage J774 
cells, junb promoter and downstream regions were likely to interact in order to 
enhance junb transcription activity (Figure 17). The structural configuration of 
junb gene, including upstream and downstream regions in macrophages can be 
another target in future studies. Furthermore, it will be essential to address 
which elements or what transcription factors contribute most significantly in 
regulating junb transcription. Identification of these transcription factors is of 
great interest to further investigate the mechanism of cytokine synergy, 
whether they contribute to the crosstalk through regulating junb. 
 
4.4 The role of downstream NF-κB sites in regulating junb 
The four NF-κB sites within junb enhancer region (Figure 15) play 
important roles in regulating junb transcription under PAMP stimulations. 
When all the four sites were mutated, the transcription of junb was 
significantly abolished. Each of these NF-κB site contribute in regulating junb 
to a certain extent, but they need to cooperate with each other in order to 
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regulate junb in the most appropriate manner. 
 
4.5 The candidate factors and potential mechanisms of regulation of junb  
    junb promoter and downstream 3'UTR were found to cooperate in 
regulating junb; the question remains on what mechanism(s) may contribute 
significantly in this process – is it the differential binding of transcription 
factors? or chromatin remodeling? The mass spectrometric analysis of the 
promoter and downstream 3'UTR co-pulldown nuclear proteins under different 
PAMP stimulations identified AATF, SSRP1 and TARDBP transcription 
factors as potential regulators of junb activity. We were not able to detect the 
binding of these TFs with junb promoter and enhancer, so the binding needs 
further verification, either by co-pulling down using nuclear extract from 
earlier time points (since chromatin remodeling occurs earlier than 
transcription) or by using antibodies from other company sources. The 
functions of these transcription factors indicate that chromatin remodeling 
may be more likely to regulate junb transcription. This may also explain how 
junb could be a fast responding gene.  
    JunB protein is shown to have sustained stability especially under R 
stimulation (Figure 5). UPP may regulate the stability of proteins by 
controlling their degradation, thus we analysis the mass spectrometry protein 
profiles from co-pull down assay using nuclear extract, especially under R 
stimulation. Result showed that the UPP related proteins showed little 
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difference between R stimulation and other (NT, I) stimulations. This may be 
that the samples used were pull-downed proteins in the nucleus, but UPP 
regulations occur in the cytoplasmic region and will not be pulled down. Thus 
seeking the UPP related factors in the whole cell lysis protein will be 
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Chapter 5: Conclusions  
junb response and regulation under viral infection conditions 
TLR3 and TLR7 are known to reside in endolysosomal membranes. 
When these TLRs encounter combinatorial PAMP stimulations (poly(I:C) and 
R848), the expression of JunB is induced and the proinflammatory cytokine 
synergy occurs. By knocking down junb, the proinflammatory cytokine 
synergy was impaired (Liu, Zhu et al., 2015). Thus, we propose a model for 
the response and regulation of junb under viral infection conditions (Figure 
20). 
After the recognition of poly(I:C) and R848 by TLR3 and TLR7, 
respectively, the pre-existing or induced TFs translocate into the nucleus. 
Depending on the types of stimulation (single or combinatorial PAMP 
stimulation), different kinds or amounts of TFs may bind to the junb promoter 
and the 3'UTR enhancer region. We found that the junb promoter and 3'UTR 
enhancer cooperate in regulating junb transcription. TFs such as NF-κB binds 
with junb downstream enhancer, and together with the contribution of TFs 
binding with junb promoter, such as TARDBP, AATF, SSRP1 and other TFs 
yet to be identified, facilitate the regulation of expression of JunB under 
stimulations. Another possibilities are: under the conditions of PAMP 
stimulations, the chromatin status of junb promoter and downstream 3'UTR 
might change, regulating the transcription of junb, or the interfere of UPP 
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contributes in JunB degradation. Consequently, the induced JunB binds to the 
promoter of proinflammatory cytokine genes, resulting in the proinflammatory 
cytokine synergy (Liu, Zhu et al., 2015), thus enabling the host immune 





Figure 20. Model for the response and regulation of junb under viral infection 
condition. TLR3 and TLR7 recognize dsRNA (poly(I:C) and ssRNA (R848), 
respectively. Depending on different stimulation conditions, different kinds 
or/and amounts of TFs bind to junb promoter, NF-κBs bind to junb promoter 
and regulate different levels of JunB expression. The induced JunB binds to 
the promoter of proinflammatory cytokine promoters, thus contributing to 
cytokine synergy.  
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Chapter 6: Future Perspectives 
    Based on this thesis work, there are several directions for future study to 
understand the mechanism of regulating junb better. 
6.1. Binding of TF candidates with junb promoter 
TFs have to bind to chromatin to be fully effective. So the actual binding 
of TFs, TARDBP, AATF and SSRP1, found in the mass spectrometric analysis 
with junb promoter and 3'UTR enhancer regions need to be verified 
experimentally. Since these TFs are known to involve in chromatin remodeling, 
the co-pull down assay by using nuclear extract proteins from earlier time 
points will be necessary, since the initiation of chromatin remodeling should 
be earlier than transcription. To verify the protein-DNA binding, one approach 
is electrophoretic mobility shift assay (EMSA). The double-stranded 
oligonucleotides predicted to be interacting with the TF candidate will be 
amplified and labeled with biotin to serve as probes. These probes will be 
incubated with nuclear extract alone or with both nuclear extract and 
antibodies against the transcription factor candidate. Samples will be run on 
gel and detected by streptavidin antibody. If a supershift can be seen, we can 
conclude that the binding of transcription factor candidate is binding 
specifically to the junb promoter region. Furthermore, comparisons of the 
EMSA shifts will be made from nuclear extracts derived from macrophages 
treated by different PAMPs. This will provide us an idea on the differential 
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nucleosome (TFs and co-factors) bound to the junb promoter. 
 
6.2 The functions of TF candidates in J774 cell line  
6.2.1 Mutagenesis of junb promoter and downstream 3'UTR regions 
From the mass spectrometry results of the different co-pulldown samples 
and the bioinformatics analysis of junb promoter and downstream 3'UTR 
regions, the TF candidates binding sites can be mapped. One way to 
investigate the functions of the TF candidates in junb induction is to generate 
different site-directed mutants within the binding sites, and the mutated junb 
promoter activity will be measured by dual luciferase reporter assay as 
described before, and compared with the wild type promoter. Another aspect 
that needed to address is the transfection of J774 cells, since transfection using 
X-tremeGENE HP DNA Transfection Reagent (Roche) influences J774 cells 
and the expression of JunB, so the efficiency and the effect on J774 cells by 
other transfection method such as nucleofection is needed to test. From this 
result we may be able to draw a conclusion about what TFs are important in 
regulating junb transcription. 
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6.2.2 Knockdown TF candidates to investigate their functions 
To investigate the functions of the TF candidates in junb induction, TF 
gene-specific siRNA knockdown may be performed in J774 cells. Then, under 
different PAMP stimulations, the residual amount of junb mRNA and JunB 
protein levels will be assay by real-time PCR and Western blot, respectively. 
To ascertain whether knockdown of the TF candidates have effect on the 
synergistic cytokine production, ELISA will be performed to quantify the key 
proinflammatory cytokines (e.g. TNFα, IL6, IL12b) produced by the 
knockdown J774 cells under PAMP stimulations. We expect that the TF 
knockdown will impair the junb promoter function and therefore abrogate the 
cytokine synergy.  
 
6.3 Investigation on chromatin remodeling  
    Chromatin remodeling is another possible mechanism in regulating junb 
transcription. It is a dynamic process of modifying the chromatin architecture 
to allow the entry of regulatory transcription machinery proteins binding to 
genomic DNA, controlling gene expression. This is an interesting aspect to dig 
deeper into in the future. Research on histone modification, nucleosome 
positioning and reorganization, and DNA methylation may be further 
investigated. 
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6.4 Investigation of UPP related proteins in regulating JunB protein 
stability 
    UPP facilitates the degradation of proteins. Blocking UPP such as the 
presence of UPP proteasome inhibitor may help maintaining JunB protein 
stability especially under the activation of MyD88 pathway. Mass 
spectrometry analysis will be needed for comparing the UPP related proteins 
profiles in whole cell lysis under different PAMPs stimulations, which may 
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